var title_f36_20_37184="Cysteamine: Drug information";
var content_f36_20_37184=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Cysteamine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block inc\" id=\"F15516218\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F15516219\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?42/7/43122?source=see_link\">",
"       Cysteamine (ophthalmic): Drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/56/12164?source=see_link\">",
"       Cysteamine (systemic): Drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323085\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Cystagon Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50 mg (100): $43.95",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     150 mg (100): $127.95",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9313 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-180.241.123.62-6A9128D992-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_20_37184=[""].join("\n");
var outline_f36_20_37184=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?42/7/43122?source=related_link\">",
"      Cysteamine (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?11/56/12164?source=related_link\">",
"      Cysteamine (systemic): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_20_37185="EB simplex Dowling-Meara 1";
var content_f36_20_37185=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86392&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86392&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Epidermolysis bullosa simplex (EBS) of Dowling-Meara",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Typical herpetiform distribution of cutaneous lesions, including blisters, erosions, crusts, and atrophic scars, in EBS Dowling-Meara.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Dedee F Murrell, MD, Johann Bauer, MD, and Martin Laimer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_20_37185=[""].join("\n");
var outline_f36_20_37185=null;
var title_f36_20_37186="Patient information: Renovascular hypertension (The Basics)";
var content_f36_20_37186=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"12\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/17167\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?31/10/31906\">",
"         Blood vessels supplying the kidneys",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_table\" href=\"mobipreview.htm?6/16/6411\">",
"          Definition of normal and high blood pressure",
"         </a>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?27/10/27809\">",
"         Patient information: Coronary heart disease (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?33/58/34722\">",
"         Patient information: High blood pressure in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?32/54/33635\">",
"         Patient information: High blood pressure in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?36/32/37380\">",
"         Patient information: High blood pressure treatment in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?9/8/9347\">",
"         Patient information: High blood pressure, diet, and weight (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Renovascular hypertension (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/renovascular-hypertension-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H15868902\">",
"      <span class=\"h1\">",
"       What is renovascular hypertension?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Renovascular hypertension is a type of high blood pressure. It happens when the renal arteries, the blood vessels that carry blood to the kidneys, become narrow (",
"      <a class=\"graphic graphic_figure graphicRef70583 \" href=\"mobipreview.htm?31/10/31906\">",
"       figure 1",
"      </a>",
"      ).",
"     </p>",
"     <p>",
"      High blood pressure puts you at risk for heart attack, stroke, and kidney disease. It does not usually cause symptoms. But it can be serious.",
"     </p>",
"     <p>",
"      When your doctor or nurse tells you your blood pressure, he or she will say 2 numbers. For instance, your doctor or nurse might say that your blood pressure is &ldquo;140 over 90.&rdquo; The top number is the pressure inside your arteries when your heart is contracting. The bottom number is the pressure inside your arteries when your heart is relaxed.",
"     </p>",
"     <p>",
"      This table shows how doctors and nurses define high and normal blood pressure (",
"      <a class=\"graphic graphic_table graphicRef59480 \" href=\"mobipreview.htm?6/16/6411\">",
"       table 1",
"      </a>",
"      ).",
"     </p>",
"     <p>",
"      Renovascular hypertension is also called &ldquo;renal artery stenosis.&rdquo;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H15868917\">",
"      <span class=\"h1\">",
"       Will I need tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Maybe. If you have renovascular hypertension, your doctor might be able to hear a &ldquo;whooshing&rdquo; sound when listening to your belly through a stethoscope.",
"     </p>",
"     <p>",
"      The doctor can also order imaging tests that create pictures of the renal arteries. But these tests are only done if the doctor thinks a procedure to open up the arteries could be helpful. &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H15868932\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;See your doctor or nurse right away if you have high blood pressure and get any of the following symptoms:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        A very bad headache",
"       </li>",
"       <li>",
"        Chest pain",
"       </li>",
"       <li>",
"        Problems breathing",
"       </li>",
"       <li>",
"        Weakness on one side of your body and not the other",
"       </li>",
"       <li>",
"        Problems speaking",
"       </li>",
"       <li>",
"        Nausea or vomiting",
"       </li>",
"       <li>",
"        Confusion",
"       </li>",
"       <li>",
"        Vision changes",
"       </li>",
"       <li>",
"        Nosebleeds",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      These can be signs of a very serious type of high blood pressure that needs to be treated as soon as possible.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H15868947\">",
"      <span class=\"h1\">",
"       How is renovascular hypertension treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatments include medicines for high blood pressure, such as:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        ACE inhibitors and ARBs - ACE inhibitors and ARBs are often grouped together, because they work in similar ways. These medicines can help prevent kidney disease.",
"        <br/>",
"        <br/>",
"        Some examples of ACE inhibitors include",
"        <a class=\"drug drug_patient\" href=\"mobipreview.htm?29/31/30197?source=see_link\">",
"         enalapril",
"        </a>",
"        ,",
"        <a class=\"drug drug_patient\" href=\"mobipreview.htm?24/49/25365?source=see_link\">",
"         captopril",
"        </a>",
"        , and",
"        <a class=\"drug drug_patient\" href=\"mobipreview.htm?9/32/9734?source=see_link\">",
"         lisinopril",
"        </a>",
"        . Some examples of ARBs include",
"        <a class=\"drug drug_patient\" href=\"mobipreview.htm?4/50/4902?source=see_link\">",
"         candesartan",
"        </a>",
"        (brand name: Atacand&reg;) and",
"        <a class=\"drug drug_patient\" href=\"mobipreview.htm?21/15/21749?source=see_link\">",
"         valsartan",
"        </a>",
"        (brand name: Diovan&reg;).",
"       </li>",
"       <li>",
"        Diuretics - Some examples of diuretics include",
"        <a class=\"drug drug_patient\" href=\"mobipreview.htm?8/21/8533?source=see_link\">",
"         chlorthalidone",
"        </a>",
"        ,",
"        <a class=\"drug drug_patient\" href=\"mobipreview.htm?10/20/10565?source=see_link\">",
"         hydrochlorothiazide",
"        </a>",
"        (also known as HCTZ), and",
"        <a class=\"drug drug_patient\" href=\"mobipreview.htm?12/14/12518?source=see_link\">",
"         furosemide",
"        </a>",
"        (brand name: Lasix&reg;).",
"       </li>",
"       <li>",
"        Calcium channel blockers - Some examples of calcium channel blockers include",
"        <a class=\"drug drug_patient\" href=\"mobipreview.htm?4/13/4309?source=see_link\">",
"         amlodipine",
"        </a>",
"        (brand name: Norvasc&reg;),",
"        <a class=\"drug drug_patient\" href=\"mobipreview.htm?1/12/1221?source=see_link\">",
"         felodipine",
"        </a>",
"        (brand name: Plendil&reg;), and",
"        <a class=\"drug drug_patient\" href=\"mobipreview.htm?6/11/6326?source=see_link\">",
"         diltiazem",
"        </a>",
"        (brand name: Cardizem&reg;). These medicines also help prevent chest pain caused by heart disease.",
"       </li>",
"       <li>",
"        Beta blockers - Some examples of beta blockers include",
"        <a class=\"drug drug_patient\" href=\"mobipreview.htm?2/27/2486?source=see_link\">",
"         atenolol",
"        </a>",
"        (brand name: Tenormin&reg;),",
"        <a class=\"drug drug_patient\" href=\"mobipreview.htm?24/28/25030?source=see_link\">",
"         metoprolol",
"        </a>",
"        (brand names: Lopressor&reg;, Toprol-XL&reg;), and",
"        <a class=\"drug drug_patient\" href=\"mobipreview.htm?42/4/43077?source=see_link\">",
"         propranolol",
"        </a>",
"        (brand name: Inderal LA&reg;).",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      This article has only some basic information on these medicines. For more detailed information about your medicines, ask your doctor or nurse for information from Lexicomp, available through UpToDate. The Lexicomp hand-outs explain how to use and store your medicines. They also list possible side effects and warn you if your medicines should not be taken with certain other medicines or foods.",
"     </p>",
"     <p>",
"      Your doctor might recommend a procedure called angioplasty to open up 1 (or possibly both) of your renal arteries. During an angioplasty, the doctor puts a thin tube into a blood vessel in the leg and advances the tube to the kidney. Then the doctor inflates a tiny balloon inside the clogged artery to reopen it. Often the doctor props open the artery using a tiny mesh tube called a stent.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H15869028\">",
"      <span class=\"h1\">",
"       Can renovascular hypertension be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You can reduce your chances of getting renovascular hypertension by keeping your blood vessels healthy. To do that, you should:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Quit smoking, if you smoke.",
"       </li>",
"       <li>",
"        Eat lots of fruits and vegetables and low-fat dairy products, but not a lot of meat or fatty foods.",
"       </li>",
"       <li>",
"        Walk, or do some form of physical activity on most days of the week.",
"       </li>",
"       <li>",
"        Lose weight, if you are overweight.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H15868895\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?33/58/34722?source=see_link\">",
"       Patient information: High blood pressure in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/10/27809?source=see_link\">",
"       Patient information: Coronary heart disease (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?32/54/33635?source=see_link\">",
"       Patient information: High blood pressure in adults (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?36/32/37380?source=see_link\">",
"       Patient information: High blood pressure treatment in adults (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?9/8/9347?source=see_link\">",
"       Patient information: High blood pressure, diet, and weight (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?36/20/37186?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 17167 Version 3.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-2522EA1FE6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_20_37186=[""].join("\n");
var outline_f36_20_37186=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15868902\">",
"      What is renovascular hypertension?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15868917\">",
"      Will I need tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15868932\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15868947\">",
"      How is renovascular hypertension treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15869028\">",
"      Can renovascular hypertension be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15868895\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/17167\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?31/10/31906\">",
"      Blood vessels supplying the kidneys",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_table\" href=\"mobipreview.htm?6/16/6411\">",
"       Definition of normal and high blood pressure",
"      </a>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/10/27809?source=related_link\">",
"      Patient information: Coronary heart disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?32/54/33635?source=related_link\">",
"      Patient information: High blood pressure in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?33/58/34722?source=related_link\">",
"      Patient information: High blood pressure in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?36/32/37380?source=related_link\">",
"      Patient information: High blood pressure treatment in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?9/8/9347?source=related_link\">",
"      Patient information: High blood pressure, diet, and weight (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_20_37187="Left ventricular afterload in chronic mitral regurgitation";
var content_f36_20_37187=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Left ventricular afterload in chronic mitral regurgitation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/20/37187/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/20/37187/contributors\">",
"     William H Gaasch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/20/37187/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/20/37187/contributors\">",
"     Catherine M Otto, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/20/37187/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/20/37187/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/20/37187/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic mitral regurgitation (MR) provides an alternate low resistance pathway for left ventricular ejection which has traditionally been thought to produce a decrease in left ventricular afterload. While this may be true in acute mitral regurgitation, some data suggest that left ventricular afterload is normal in patients with compensated chronic MR and increased in those with chronic decompensated MR.",
"   </p>",
"   <p>",
"    This topic review will begin with the definitions of left ventricular afterload and wall stress and then discuss the issues relating to left ventricular afterload in chronic MR. A discussion of the pathophysiology of this disorder is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/2/36901?source=see_link\">",
"     \"Pathophysiology and stages of chronic mitral regurgitation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     LEFT VENTRICULAR AFTERLOAD AND WALL STRESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Left ventricular (LV) afterload can be considered the load or force developed by the ventricle during systole, and is best measured as systolic wall stress. Afterload or wall stress and myocardial fiber shortening are inversely related. As a result, an increase in afterload will be accompanied by a decrease in shortening (or ejection fraction), while a decrease in afterload will accompanied by an increase in shortening (or ejection fraction).",
"   </p>",
"   <p>",
"    Stress is defined as the force or load per unit cross-sectional area of a material. This is an engineering term used to compare loads borne by different sized elements of a material. In a spherical model of the left ventricle, wall stress is directly proportional to the product of transmural pressure and chamber radius divided by the wall thickness (",
"    <a class=\"graphic graphic_figure graphicRef58408 \" href=\"mobipreview.htm?40/2/41003\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    &nbsp;LV wall stress &nbsp; = &nbsp; (P &nbsp;x &nbsp;R) &nbsp;&divide; &nbsp;(2 &nbsp;x &nbsp;Th)",
"   </p>",
"   <p>",
"    where P = pressure, R = radius, and Th = wall thickness. As a result, if a given hemodynamic load (pressure) is borne by a smaller amount of a material (myocardium), the stress on that material will be greater.",
"   </p>",
"   <p>",
"    However, this mathematical definition of left ventricle wall stress is overly simplistic since:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Geometry in the left ventricle is much more complex than that represented by a simple sphere. Ellipsoidal or cylindrical models more accurately represent the ventricle.",
"     </li>",
"     <li>",
"      Several components of stress exist within the wall of the ventricle. Meridional stresses are directed from apex to base while circumferential or hoop stresses are directed circumferentially at the equator.",
"     </li>",
"     <li>",
"      Wall stress varies over time since LV pressure, radius, and wall thickness are continuously changing throughout the cardiac cycle. As a result, afterload can be calculated at the instant of aortic valve opening, at the end of ejection, or at any instant throughout systole. Clinical investigators use peak systolic stress, end-systolic stress, or mean systolic stress as indices of afterload.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     AFTERLOAD IN CHRONIC MITRAL REGURGITATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is widely held that chronic MR creates a systolic \"unloading\" effect by providing a low resistance path for ejection into the left atrium. Such an effect is thought to cause an increase in the LV ejection fraction by virtue of the inverse stress-shortening relation. Furthermore, mitral valve replacement has been thought to cause an increase in systolic load and a decrease in the ejection fraction by removing the low resistance leak. Data published in the past decade indicate that these concepts are oversimplified, if not largely incorrect.",
"   </p>",
"   <p>",
"    As an example, noninvasive (echocardiographic) measurements of LV volume, mass, and function in one study of patients with chronic MR showed that meridional wall stresses were not reduced [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37187/abstract/1\">",
"     1",
"    </a>",
"    ]. To the contrary, peak-systolic stress tended to be increased. End-systolic stress was normal in compensated MR, but was increased significantly in decompensated MR.",
"   </p>",
"   <p>",
"    Another report confirmed these observations using invasive (cardiac catheterization) hemodynamic and angiographic measurements [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37187/abstract/2\">",
"     2",
"    </a>",
"    ]. Peak-systolic stress was modestly increased in both compensated and decompensated hearts; end-systolic wall stress was especially high in decompensated MR. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/2/36901?source=see_link\">",
"     \"Pathophysiology and stages of chronic mitral regurgitation\"",
"    </a>",
"    .) Others have noted normal to increased systolic stress levels in chronic MR, but have not analyzed separately the data from compensated or decompensated ventricles.",
"   </p>",
"   <p>",
"    Normal or increased wall stress occurs in chronic MR because of opposite effects resulting from the regurgitant pathway and the enlarged left ventricle. In this setting, the low resistance leak into the left atrium unloads the left ventricle through an effect on systolic pressure and radius. However, the large left ventricle chamber size (radius) and especially the increased ratio of radius to wall thickness appear to counteract the effect of the low resistance regurgitant leak. The net result is normal or increased systolic wall stress [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37187/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     AFTERLOAD FOLLOWING CORRECTIVE SURGERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The functional state of the left ventricle before surgery and the nature of the corrective surgery both influence the left ventricular response to surgical correction of the regurgitant lesion. It is therefore useful to discuss these two issues separately in order to dissect those factors responsible for changes in afterload postoperatively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Functional status of the ventricle",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with compensated and decompensated MR differ significantly in LV size and function, and in the ventricular response to valve replacement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37187/abstract/1,4\">",
"     1,4",
"    </a>",
"    ]. Such differences in the response to surgery can be illustrated in the form of stress-dimension plots (",
"    <a class=\"graphic graphic_figure graphicRef58408 \" href=\"mobipreview.htm?40/2/41003\">",
"     figure 1",
"    </a>",
"    ) and can be summarized as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with compensated MR display a salutary decrease in end-diastolic dimension after valve replacement. Systolic wall stress remains normal.",
"     </li>",
"     <li>",
"      Patients with decompensated MR have persistent postoperative LV enlargement and an increase in end-systolic stress.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The decrease in fiber shortening and ejection fraction in decompensated MR is related in part to a postoperative change in ventricular geometry and an increase in afterload. In contrast, systolic stress does not increase in compensated MR despite closure of the low-resistance left atrial leak. As a result, the postoperative fall in ejection fraction in compensated ventricles cannot be ascribed to excess afterload.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Mitral valve replacement versus repair",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mitral valve replacement or repair generally produce similar changes in LV end-diastolic volume. In one report, for example, peak systolic stress fell and end-systolic stress was unchanged with both procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37187/abstract/5\">",
"     5",
"    </a>",
"    ]. However, differences were observed in their effects on ejection fraction. Valve replacement caused a significant decline in ejection fraction (60 &plusmn; 10 versus 48 &plusmn; 10 percent, before and after surgery, respectively) while valve repair produced no change (64 &plusmn; 5 versus 61 &plusmn; 16 percent).",
"   </p>",
"   <p>",
"    The different effects on ejection fraction from the two procedures can be explained by severance of the chordae tendineae with valve replacement and preservation of the subvalvular apparatus with repair. This is illustrated by a study in which ventricular function in patients undergoing valve replacement with chordal preservation was compared with that in patients undergoing valve replacement with chordal transection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37187/abstract/6\">",
"     6",
"    </a>",
"    ]. Postoperatively, afterload was lower and the ejection fraction was higher in the patients with chordal preservation.",
"   </p>",
"   <p>",
"    A second retrospective study of 612 patients undergoing mitral valve repair or replacement also reported that preservation of the subvalvular apparatus improved outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37187/abstract/7\">",
"     7",
"    </a>",
"    ]. Mortality at 30 days was lower in the patients undergoing valve repair or replacement with subvalvular apparatus preservation compared to those with replacement without preservation (1.8 and 1.5 versus 5.0 percent). Overall survival at seven years was also better in the first two groups compared to the latter (71 and 66 versus 63 percent). Subvalvular apparatus preservation was an independent predictor for improved outcome.",
"   </p>",
"   <p>",
"    In summary, published data do not support the notion that surgical correction of chronic MR uniformly produces a postoperative increase in systolic wall stress [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37187/abstract/8\">",
"     8",
"    </a>",
"    ]. Increased afterload may contribute to a decline in ejection fraction in patients with decompensated MR, especially if chordal preservation techniques are not employed. In compensated ventricles, however, afterload does not increase postoperatively with valve replacement",
"    <strong>",
"     or",
"    </strong>",
"    repair.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5713440\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Left ventricular (LV) afterload can be considered the load or force developed by the ventricle during systole, and is best measured as systolic wall stress. Afterload or wall stress and myocardial fiber shortening are inversely related. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Left ventricular afterload and wall stress'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Normal or increased wall stress occurs in chronic MR because of opposing effects of the regurgitant volume and the dilated left ventricle (with increased ratio of radius to wall thickness). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Afterload in chronic mitral regurgitation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chronic mitral regurgitation (MR) provides an alternate low resistance pathway for left ventricular ejection that has traditionally been thought to produce a decrease in left ventricular afterload. While this may be true in acute mitral regurgitation, some data suggest that left ventricular afterload is normal in patients with compensated chronic MR and increased in those with chronic decompensated MR. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The different effects on ejection fraction between mitral valve replacement and repair can be explained by severance of the chordae tendineae with valve replacement and preservation of the subvalvular apparatus with repair. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Mitral valve replacement versus repair'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Valve replacement or repair&nbsp;in decompensated MR&nbsp;results in a postoperative change in ventricular systolic geometry and an increase in afterload&nbsp;that leads&nbsp;to a decrease in the ejection fraction.&nbsp;In those with compensated MR, severance of the chordae tendinae and disruption of the functional subvalvular components of the mitral valve can contribute to a decline in the ejection fraction. Preservation of the chordae preserves the ejection fraction in patients with chronic compensated MR. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Afterload following corrective surgery'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37187/abstract/1\">",
"      Zile MR, Gaasch WH, Levine HJ. Left ventricular stress-dimension-shortening relations before and after correction of chronic aortic and mitral regurgitation. Am J Cardiol 1985; 56:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37187/abstract/2\">",
"      Corin WJ, Monrad ES, Murakami T, et al. The relationship of afterload to ejection performance in chronic mitral regurgitation. Circulation 1987; 76:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37187/abstract/3\">",
"      Gaasch WH, Zile MR. Left ventricular function after surgical correction of chronic mitral regurgitation. Eur Heart J 1991; 12 Suppl B:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37187/abstract/4\">",
"      Carabello BA. Mitral valve disease. Curr Probl Cardiol 1993; 18:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37187/abstract/5\">",
"      Corin WJ, S&uuml;tsch G, Murakami T, et al. Left ventricular function in chronic mitral regurgitation: preoperative and postoperative comparison. J Am Coll Cardiol 1995; 25:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37187/abstract/6\">",
"      Rozich JD, Carabello BA, Usher BW, et al. Mitral valve replacement with and without chordal preservation in patients with chronic mitral regurgitation. Mechanisms for differences in postoperative ejection performance. Circulation 1992; 86:1718.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37187/abstract/7\">",
"      Lee EM, Shapiro LM, Wells FC. Importance of subvalvular preservation and early operation in mitral valve surgery. Circulation 1996; 94:2117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37187/abstract/8\">",
"      Goldfine H, Aurigemma GP, Zile MR, Gaasch WH. Left ventricular length-force-shortening relations before and after surgical correction of chronic mitral regurgitation. J Am Coll Cardiol 1998; 31:180.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8113 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-FB51BAF4EE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_20_37187=[""].join("\n");
var outline_f36_20_37187=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H5713440\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      LEFT VENTRICULAR AFTERLOAD AND WALL STRESS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      AFTERLOAD IN CHRONIC MITRAL REGURGITATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      AFTERLOAD FOLLOWING CORRECTIVE SURGERY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Functional status of the ventricle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Mitral valve replacement versus repair",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5713440\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/8113\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8113|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?40/2/41003\" title=\"figure 1\">",
"      The law of Laplace",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/2/36901?source=related_link\">",
"      Pathophysiology and stages of chronic mitral regurgitation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_20_37188="3D airway anatomy MRI";
var content_f36_20_37188=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F77480&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F77480&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 478px\">",
"   <div class=\"ttl\">",
"    Volumetric reconstruction of axial MR images in a normal subject and patient with sleep apnea",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 458px; height: 357px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The mandible is depicted in white, the tongue in red, the soft palate in blue, the lateral parapharyngeal fat pads in yellow, and the lateral/posterior pharyngeal walls in green. The airway is depicted in gray/white. The normal subject has a larger airway than the patient with sleep apnea. The tongue, soft palate, parapharyngeal fat pads, and lateral pharyngeal walls of the patient with sleep apnea are all larger than in the normal subject.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Richard J Schwab, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_20_37188=[""].join("\n");
var outline_f36_20_37188=null;
var title_f36_20_37189="Sumatriptan and naproxen: Patient drug information";
var content_f36_20_37189=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Sumatriptan and naproxen: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/35/41527?source=see_link\">",
"     see \"Sumatriptan and naproxen: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F6103470\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Treximet&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10030146\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700782",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may raise the chance of very bad and sometimes deadly heart and blood vessel side effects like heart attack and stroke. The risk may be greater if you have heart disease or risks for heart disease. The risk may be greater with long-term use. Do not use this drug right before or after bypass heart surgery.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700792",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may raise the chance of ulcers or bleeding from the stomach or bowel. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700568",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A very bad and sometimes deadly health problem called serotonin syndrome may happen. The risk may be greater if you take this drug with certain other drugs. Call your doctor right away if you have dizziness, very bad headache, agitation, hallucinations, fever, fast heartbeat, a heartbeat that does not feel normal, flushing, seizures, shakiness, sweating a lot, change in balance, change in thinking clearly and with logic, very bad upset stomach and throwing up, or very bad loose stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10030148\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691956",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat migraine headaches.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10030147\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to sumatriptan, naproxen, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703462",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Some types of migraine headaches, chest pain or pressure, diseased arteries going to the legs, heart attack, heart bypass surgery, heart disease, very bad liver disease, poor bowel blood flow, stroke, or very high blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701342",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are using this drug to stop you from getting migraine headaches.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken certain drugs used for low mood (depression) like isocarboxazid, phenelzine, or tranylcypromine or drugs used for Parkinson's disease like selegiline or rasagiline in the last 14 days. Taking this drug within 14 days of those drugs can cause very bad high blood pressure. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703841",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, or zolmitriptan in the last 24 hours.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703856",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken ergotamine, methysergide, or dihydroergotamine in the last 24 hours.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701061",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are more than 24 weeks pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10030152\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697753",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use care if you have risks for heart disease (high blood pressure, high cholesterol, overweight, high blood sugar (diabetes), cigarette smoking, man older than 40 years of age, other family members with early heart disease, woman after change of life). Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697173",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have asthma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10030153\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10030155\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698625",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure, a fast heartbeat, or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698619",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in strength on 1 side is greater than the other, trouble speaking or thinking, change in balance, or blurred eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699030",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache or if headache is not better after the first dose.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698599",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Agitation, twitching, sweating, or muscle stiffness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699050",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad swelling or pain of hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698607",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Black, tarry, or bloody stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698609",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Blood in the urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10030150\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695904",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with food to stop an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695714",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695208",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your headache comes back after the first dose, 1 more dose may be taken 2 hours after the first one.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698544",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a diary of your headaches.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10030151\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696577",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is taken on an as needed basis. Do not take more than 2 tablets in 24 hours.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10030156\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10030157\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12129 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-78.134.254.52-42756325B5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_20_37189=[""].join("\n");
var outline_f36_20_37189=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6103470\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030146\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030148\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030147\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030152\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030153\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030155\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030150\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030151\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030156\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030157\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?40/35/41527?source=related_link\">",
"      Sumatriptan and naproxen: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_20_37190="Neural circuitry of panic attacks";
var content_f36_20_37190=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PSYCH%2F58548&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PSYCH%2F58548&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 515px\">",
"   <div class=\"ttl\">",
"    Neural circuitry of panic attacks",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 495px; height: 434px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Original figure modified for this publication. Roy-Byrne, P, Craske, MG, Stein, MB. Panic disorder. Lancet 2006; 368:1023. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_20_37190=[""].join("\n");
var outline_f36_20_37190=null;
var title_f36_20_37191="Light microscopy granulosa cell";
var content_f36_20_37191=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F60037&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F60037&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Juvenile type granulosa cell tumor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 384px; height: 256px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph of a juvenile type granulosa cell tumor from the ovary. Note the two cystic spaces that contain blue, mucinous material (black arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dr. Marisa Nucci, Department of Pathology, Brigham and Womens Hospital, Boston, MA.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_20_37191=[""].join("\n");
var outline_f36_20_37191=null;
var title_f36_20_37192="Etiology, clinical presentation, and diagnosis of chylothorax";
var content_f36_20_37192=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Etiology, clinical presentation, and diagnosis of chylothorax",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/20/37192/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/20/37192/contributors\">",
"     John E Heffner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/20/37192/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/20/37192/contributors\">",
"     Steven A Sahn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/20/37192/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/20/37192/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/20/37192/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chylothorax is caused by disruption or obstruction of the thoracic duct or its tributaries that results in leakage of chyle (lymphatic fluid of intestinal origin) into the pleural space. Chylous ascites can also flow into the pleural space. The fluid typically has a high triglyceride content and often a turbid or milky white appearance. In contrast, a cholesterol pleural effusion, which can also have a milky appearance, has a high concentration of cholesterol or lecithin-globulin complexes that accumulate due to pleural inflammation or infection.",
"   </p>",
"   <p>",
"    Understanding of the anatomy of the thoracic duct, the constituents of chyle, and the diverse etiologies of chylothorax is important to the accurate and efficient diagnosis of chylothorax.",
"   </p>",
"   <p>",
"    The etiology, clinical presentation, and diagnosis of chylothorax will be reviewed here. The management of chylothorax, the evaluation and management of cholesterol effusions, and general issues regarding the evaluation and treatment of pleural effusions are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/32/31241?source=see_link\">",
"     \"Management of chylothorax\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/45/31448?source=see_link\">",
"     \"Clinical presentation, diagnosis and management of cholesterol effusions\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/7/16505?source=see_link\">",
"     \"Diagnostic evaluation of a pleural effusion in adults: Initial testing\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/36/2632?source=see_link\">",
"     \"Diagnostic evaluation of pleural effusion in adults: Additional tests for undetermined etiology\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/56/21384?source=see_link\">",
"     \"Imaging of pleural effusions in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/53/36695?source=see_link\">",
"     \"Mechanisms of pleural liquid accumulation in disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CHYLOTHORAX VERSUS CHOLESTEROL EFFUSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cholesterol effusions and chylothoraces both classically have a milky or opalescent appearance. However, their etiologies and therapy differ, making it important to distinguish them.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A chylothorax occurs when lymph fluid accumulates in the pleural space due to disruption or obstruction of the thoracic duct. Chylothoraces contain a high concentration of triglycerides as chylomicrons, unless the patient has no dietary fat ingestion [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/1-4\">",
"       1-4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Cholesterol effusions (also known as a pseudochylothorax or chyliform effusion) are much less common than chylothoraces and contain a high concentration of cholesterol. These effusions typically occur in patients with thickened and sometimes calcified pleural surfaces in the setting of chronic pleural inflammation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/5,6\">",
"       5,6",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/45/31448?source=see_link\">",
"       \"Clinical presentation, diagnosis and management of cholesterol effusions\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ANATOMY OF THE THORACIC DUCT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Generally, the thoracic duct ascends from the cisterna chyli (sac at the lower end of the thoracic duct into which the intestinal and two lumbar lymphatic trunks drain), which lies just anterior to the first or second lumbar vertebra, and passes through the aortic hiatus of the diaphragm to enter the posterior mediastinum (",
"    <a class=\"graphic graphic_figure graphicRef57280 \" href=\"mobipreview.htm?9/19/9525\">",
"     figure 1",
"    </a>",
"    ), although wide anatomic variation exists [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/7\">",
"     7",
"    </a>",
"    ]. The thoracic duct continues cephalad in a rightward position between the aorta and azygos vein until it reaches the approximate level of the fifth thoracic vertebra, where it crosses over the vertebral column behind the esophagus and continues in the left posterior mediastinum. The thoracic duct in this region is 2 to 3 mm in diameter and passes behind the aortic arch adjacent to the left side of the esophagus and behind the left subclavian artery. It then arches over the subclavian artery in the anterolateral superior mediastinum, descending to empty into the venous circulation in the region of the left jugular and subclavian veins.",
"   </p>",
"   <p>",
"    In some patients, two thoracic ducts exist within the mediastinum, and occasionally a single thoracic duct may empty into right-sided venous structures.",
"   </p>",
"   <p>",
"    The anatomy of the thoracic duct determines the location of the effusion seen with duct injury or obstruction. Because the thoracic duct crosses the mediastinum at the fifth thoracic vertebral body, lymphatic injury or obstruction below this level results in a right&ndash;sided pleural effusion. In contrast, disease above this level usually leads to a left-sided effusion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CHYLE COMPOSITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The thoracic duct carries chyle, which is defined as lymphatic fluid of intestinal origin, to the bloodstream.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chyle has a high content of triglycerides in the form of chylomicrons, which produce the milky, opalescent appearance of lymphatic fluid. This milky appearance may clear during a fast and rapidly returns after ingestion of dietary fat.",
"     </li>",
"     <li>",
"      Chyle also contains lymphocytes (primarily T lymphocytes) as the major cellular component, with concentrations that range from 400 to 6800",
"      <span class=\"nowrap\">",
"       cells/microL,",
"      </span>",
"      and is bacteriostatic [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The electrolyte content of chyle is similar to plasma, and the protein concentration is usually greater than 3",
"      <span class=\"nowrap\">",
"       g/dL.",
"      </span>",
"     </li>",
"     <li>",
"      Chyle is also rich in immunoglobulins and contains all of the fat soluble vitamins absorbed from the intestine.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As the thoracic duct passes through the mediastinum, it also receives nonchylous lymph from tributaries that drain regions of the pulmonary parenchyma and parietal pleura [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/9\">",
"     9",
"    </a>",
"    ]. The sum of these sources accounts for a total lymphatic flow through the thoracic duct of 1500 to 2400",
"    <span class=\"nowrap\">",
"     mL/day",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/10\">",
"     10",
"    </a>",
"    ]. This flow increases with dietary intake of fat, particularly long-chain triglycerides.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     ETIOLOGY OF CHYLOTHORAX",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiologies of chylothorax can be categorized as nontraumatic or traumatic (",
"    <a class=\"graphic graphic_table graphicRef61456 \" href=\"mobipreview.htm?32/27/33212\">",
"     table 1",
"    </a>",
"    ). Two large single center studies have retrospectively assessed the etiology of chylothorax [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/7,11\">",
"     7,11",
"    </a>",
"    ]. The largest of these studied 203 patients treated over a 21-year period and found a nearly equal incidence of traumatic (50 percent) and nontraumatic (44 percent) etiologies; the remaining patients (6 percent) were diagnosed with idiopathic chylothorax after exhaustive evaluation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/11\">",
"     11",
"    </a>",
"    ]. In contrast, the other large but older case series found that 72 percent of chylothoraces were nontraumatic (",
"    <a class=\"graphic graphic_table graphicRef61456 \" href=\"mobipreview.htm?32/27/33212\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/7\">",
"     7",
"    </a>",
"    ]. The etiology of chylothorax likely also varies by the patient population managed in the reporting institution.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Nontraumatic causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malignancy is the leading cause of nontraumatic chylothorax. Lymphoma, chronic lymphocytic leukemia, and metastatic cancer have all been noted in association with chylothorax [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/11\">",
"     11",
"    </a>",
"    ]. The lower incidence of chylothorax related to lymphoma in the series reported in 2005 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/11\">",
"     11",
"    </a>",
"    ], compared with the older series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/7\">",
"     7",
"    </a>",
"    ], probably relates to the earlier diagnosis of lymphoma and prompt initiation of effective therapy, prior to development of chylothorax. Most chylothoraces associated with lymphoma occur in patients with advanced disease.",
"   </p>",
"   <p>",
"    Approximately 5 to 10 percent of chylothoraces are idiopathic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. However, many idiopathic chylothoraces are eventually linked to an occult neoplasm after extensive patient evaluation or prolonged observation.",
"   </p>",
"   <p>",
"    Less common causes include Castleman's disease (angiocentric or giant lymph node hyperplasia), sarcoidosis, Kaposi sarcoma, yellow nail syndrome, histoplasmosis, tuberculosis, lymphangioleiomyomatosis (LAM), Noonan syndrome, Down syndrome, congenital lymphangiectasia, multiple myeloma, Waldenstrom macroglobulinemia, amyloidosis, filariasis, venous thrombosis, thoracic irradiation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/13,14\">",
"     13,14",
"    </a>",
"    ], superior vena cava syndrome, subclavian vein thrombosis, thoracic duct cysts, constrictive pericarditis, and goiter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/8,11,15-21\">",
"     8,11,15-21",
"    </a>",
"    ]. The mechanism of chylothorax in granulomatous infections like tuberculosis and histoplasmosis appears to be mediastinal lymphadenitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. Delayed chylothorax has been reported as long as 23 years following irradiation for Hodgkin lymphoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/51/6970?source=see_link\">",
"     \"Castleman's disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/25/21914?source=see_link\">",
"     \"Clinical manifestations and diagnosis of sarcoidosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/30/4586?source=see_link&amp;anchor=H7596701#H7596701\">",
"     \"Pulmonary lymphangioleiomyomatosis\", section on 'Complications'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/61/27610?source=see_link&amp;anchor=H16#H16\">",
"     \"Clinical presentation and diagnosis of non-Hodgkin lymphoma\", section on 'Chest and lungs'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/27/23993?source=see_link&amp;anchor=H12#H12\">",
"     \"Pleural effusions in HIV-infected patients\", section on 'Kaposi sarcoma'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/37/34393?source=see_link&amp;anchor=H17#H17\">",
"     \"Nonimmune hydrops fetalis\", section on 'Thoracic abnormalities'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/47/762?source=see_link\">",
"     \"Epidemiology, pathogenesis, clinical manifestations and diagnosis of Waldenstr&ouml;m macroglobulinemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/31/1530?source=see_link\">",
"     \"An overview of amyloidosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/50/3881?source=see_link&amp;anchor=H11#H11\">",
"     \"Protein-losing gastroenteropathy\", section on 'Primary intestinal lymphangiectasia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Chylothorax is occasionally seen when fluid from chylous ascites (eg, caused by processes such as lymphoma, cirrhosis, congenital lymphatic abnormalities, and lymphatic filariasis) leaks across the diaphragm into the pleural space. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/10/168?source=see_link&amp;anchor=H1#H1\">",
"     \"Chylous, bloody, and pancreatic ascites\", section on 'Chylous ascites'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Traumatic causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disruption of the thoracic duct anywhere along its course can cause a chylothorax [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/23\">",
"     23",
"    </a>",
"    ]. Surgical procedures, which account for the majority of cases of traumatic chylothorax, in the area of the thoracic duct or nearby structures can result in disruption of the thoracic duct or shearing of lymphatic tributaries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. Esophagectomy, pulmonary resection with lymph node dissection, and surgery for congenital heart disease (including heart-lung transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/26\">",
"     26",
"    </a>",
"    ]) appear to carry the greatest risk, but thoracic duct injury has been reported in association with almost every thoracic surgical procedure, and may also complicate surgery of the neck or abdomen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/11,27\">",
"     11,27",
"    </a>",
"    ]. Injury to the intraabdominal portion of the thoracic duct can cause chylous ascites that passes through the diaphragm, resulting in a chylothorax. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/29/43481?source=see_link&amp;anchor=H89118831#H89118831\">",
"     \"Esophagectomy: Complications and management\", section on 'Chylothorax'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/36/32329?source=see_link&amp;anchor=H15#H15\">",
"     \"Sequelae and complications of pneumonectomy\", section on 'Chylothorax'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/21/16728?source=see_link&amp;anchor=H14#H14\">",
"     \"Pleural effusions following cardiac surgery\", section on 'Chylothorax'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/22/32103?source=see_link&amp;anchor=H10#H10\">",
"     \"The pleura in lung transplantation\", section on 'Chylothorax'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/6/99?source=see_link&amp;anchor=H18#H18\">",
"     \"Heart-lung transplantation\", section on 'Chylothorax'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Nonsurgical traumatic chylothorax can complicate central line placement, pacemaker implantation, embolization of pulmonary arteriovenous malformations, and chest trauma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/2/19497?source=see_link&amp;anchor=H5#H5\">",
"     \"Child abuse: Injuries of the thorax; abdomen; retroperitoneum; and pelvis\", section on 'Chylothorax'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cases of iatrogenic pseudochylothorax due to extravasation of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/40/42628?source=see_link\">",
"     total parenteral nutrition",
"    </a>",
"    fluid containing a high concentration of triglycerides from a central vein into pleural space have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/28,29\">",
"     28,29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with chylothoraces usually present with signs and symptoms induced by the mechanical effects of a pleural effusion. Patients with nontraumatic chylothoraces frequently experience a gradual onset of decreased exercise tolerance, dyspnea, a heavy feeling in the chest, and fatigue. Fever and chest pain are rare because chyle within the pleural space does not evoke an inflammatory response [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/30\">",
"     30",
"    </a>",
"    ]. Chyloptysis (expectorating chylous fluid) due to a pleurobronchial fistula is an exceedingly rare manifestation of chylothorax [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/31\">",
"     31",
"    </a>",
"    ]. As a variety of medical procedures (eg, ventral venous catheterization, esophageal embolectomy) and types of surgery are associated with chylothorax, patients should be directly asked about any history of such interventions (",
"    <a class=\"graphic graphic_table graphicRef61456 \" href=\"mobipreview.htm?32/27/33212\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The onset of a posttraumatic chylothorax may be delayed for as long as 10 days after the traumatic event. In surgical patients, the chylothorax may be first detected as a pleural effusion on serial radiographic evaluations or by the persistent drainage of pleural fluid from a preexisting chest tube. A chylothorax occurring in a postpneumonectomy space may be especially difficult to diagnose. Unusually rapid postoperative filling of the pneumonectomy space with fluid, and mediastinal shift to the contralateral side (\"tension chylothorax\") are suggestive radiographic findings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    On physical examination, findings of decreased breath sounds and dullness to percussion may be present depending of the size and location of the effusion.",
"   </p>",
"   <p>",
"    Pleural effusion is unilateral in approximately 78 percent and involves the right hemithorax in 67 percent and left hemithorax in 33 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H183969546\">",
"    <span class=\"h1\">",
"     EVALUATION AND DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A chylothorax may come to medical attention when a pleural effusion is noted on a chest radiograph obtained to evaluate dyspnea or for postoperative surveillance, or when milky fluid is noted during thoracentesis or in chest tube drainage. As a milky or opalescent appearance of the pleural fluid is only noted in approximately half the patients, a high degree of suspicion is needed, particularly in patients who have had chest, neck, or abdominal surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/34\">",
"     34",
"    </a>",
"    ]. Pleural fluid analysis is performed to look for the characteristic pattern of elevated triglyceride levels. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Chylothorax versus cholesterol effusion'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Once a chylothorax has been diagnosed, imaging techniques are used to identify the site and cause of chyle leakage. The gold standard for the diagnosis of a chylothorax has been demonstration of chyle leakage by direct visualization or lymphangiography. However, cases have been described where the fluid characteristics suggest chylothorax, but leakage is not confirmed as it is too slow or diffuse to visualize.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6014926\">",
"    <span class=\"h2\">",
"     Laboratory testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The routine laboratory testing obtained in patients with a pleural effusion includes a complete blood count and differential to screen for underlying diseases, and also serum glucose, total protein and lactic dehydrogenase (LDH) for comparison with pleural fluid values. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/7/16505?source=see_link&amp;anchor=H3#H3\">",
"     \"Diagnostic evaluation of a pleural effusion in adults: Initial testing\", section on 'Pleural fluid analysis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Pleural fluid analysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial diagnostic test for patients suspected to have chylothorax is analysis of pleural fluid collected by thoracentesis or from a preexisting chest tube. Samples of fluid are sent for cell count and differential, pH, triglycerides, cholesterol, glucose, lactic dehydrogenase (LDH), total protein, cytology, and microbiologic smear and culture. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/23/12663?source=see_link\">",
"     \"Diagnostic thoracentesis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/7/16505?source=see_link\">",
"     \"Diagnostic evaluation of a pleural effusion in adults: Initial testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H229690\">",
"    <span class=\"h3\">",
"     Appearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;The appearance of fluid from a chylothorax can be milky, sanguineous, or serous. Detection of milky appearing fluid suggests the presence of a chylothorax, a cholesterol pleural effusion, or an empyema. However, the absence of a milky appearance does not exclude a chylothorax, especially if the patient is malnourished, fasting, or on a low fat diet [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/34\">",
"     34",
"    </a>",
"    ]. One report, for example, evaluated 38 patients with chylous pleural effusions as defined by the presence of chylomicrons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/35\">",
"     35",
"    </a>",
"    ]. The pleural fluid was described as chylous (milky) in 18 (47 percent), bloody in 10 (26 percent), yellow turbid in four (11 percent), green turbid in one (3 percent), and &ldquo;other&rdquo; in five (13 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/35\">",
"     35",
"    </a>",
"    ]. Thus, the possible presence of a chylothorax should be considered in any patient who presents with a persistent or recurrent pleural effusion of obscure etiology that is turbid, bloody, or serosanguineous. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Chylothorax versus cholesterol effusion'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The supernatant of the pleural fluid from a chylothorax typically fails to clear after centrifugation, whereas &ldquo;milky&rdquo; appearing empyema fluid clears with centrifugation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11897784\">",
"    <span class=\"h3\">",
"     Cell counts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cell counts of fluid from chylothoraces reveal a predominance of lymphocytes, usually greater than 80 percent of the total nucleated cell count, reflecting the cellular composition of lymph [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/37\">",
"     37",
"    </a>",
"    ]. The lymphocytes are largely a polyclonal population of T cells.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H229718\">",
"    <span class=\"h3\">",
"     Lipid analysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measurement of the pleural fluid triglyceride content is key to the diagnosis of a suspected chylothorax (",
"    <a class=\"graphic graphic_figure graphicRef86646 \" href=\"mobipreview.htm?3/61/4062\">",
"     figure 2",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Chylothorax versus cholesterol effusion'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A pleural fluid triglyceride concentration greater than 110",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (1.24",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      strongly supports the diagnosis. Fifteen percent (15 percent) of chylothoraces, however, have pleural fluid triglyceride concentrations less than 110",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      and 3 percent have values less than 50",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/34,38\">",
"       34,38",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A triglyceride level below 110",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (1.24",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      should be followed by lipoprotein electrophoresis of the pleural fluid if a chylothorax remains clinically suspected [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Detection of chylomicrons in the pleural fluid by lipoprotein electrophoresis confirms the presence of a chylothorax [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/34,35\">",
"       34,35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The cholesterol level in a chylothorax is generally less than 200",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (5.18",
"      <span class=\"nowrap\">",
"       mmol/L).",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Fat globules may be noted on Sudan III staining, which stains chylomicrons orange, but this testing is rarely performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H229728\">",
"    <span class=\"h3\">",
"     Other chemistries",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chylothorax generally results in an exudative pleural effusion; however, transudative chylothorax has been reported in small numbers of patients with amyloidosis, cirrhosis, nephrotic syndrome, superior vena cava obstruction, heart failure, and chylous ascites that has crossed the diaphragm into the pleural space [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/17,34,40\">",
"     17,34,40",
"    </a>",
"    ]. Lactic dehydrogenase (LDH) in chyle is typically low and remains in the transudative range in chylous pleural fluid [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/40\">",
"     40",
"    </a>",
"    ]. In some but not all series, elevation of LDH in chylous pleural fluid was associated with a co-existing condition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/34,40\">",
"     34,40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/7/16505?source=see_link&amp;anchor=H5#H5\">",
"     \"Diagnostic evaluation of a pleural effusion in adults: Initial testing\", section on 'Characterization'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Chylothorax due to chylous ascites that has crossed the diaphragm usually has biochemical characteristics that match the ascitic fluid from that patient. Measurement of the pleural fluid to serum glucose ratio assists in differentiating a chylous effusion (ratio &lt;1) from pleural fluid due to the extravasation of lipid and glucose-containing parenteral nutrition into the pleural space (ratio &gt;1) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Chylous fluid usually has a pH that ranges from 7.40 to 7.80 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H183969561\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conventional chest radiography can identify the side of the chest with the effusion but is less helpful in determining the etiology. Chest computed tomography (CT) of the thorax and abdomen is typically needed to identify the presence of abnormal lymphadenopathy or mediastinal masses and the site of thoracic duct rupture. When the site of chyle leakage remains uncertain after chest CT, lymphangiography or lymphoscintigraphy may be helpful.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10472842\">",
"    <span class=\"h3\">",
"     Computed tomography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Computed tomography (CT) of the thorax and abdomen is typically performed, looking for mediastinal and retroperitoneal lymphadenopathy or masses. Careful attention is paid to the course of the thoracic duct to identify mediastinal or retroperitoneal lymphadenopathy or a cystic lesion suggestive of mediastinal lymphangioma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/42\">",
"     42",
"    </a>",
"    ]. CT scanning also may demonstrate other mediastinal (eg, substernal goiter, vascular thrombosis), cardiac (eg, constrictive pericarditis), or pulmonary (eg, manifestations of lymphangioleiomyomatosis) abnormalities that are responsible for the chylothorax (",
"    <a class=\"graphic graphic_table graphicRef61456 \" href=\"mobipreview.htm?32/27/33212\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/43\">",
"     43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/30/4586?source=see_link&amp;anchor=H7596701#H7596701\">",
"     \"Pulmonary lymphangioleiomyomatosis\", section on 'Complications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10472849\">",
"    <span class=\"h3\">",
"     Lymphangiography and lymphoscintigraphy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiology and site of leakage in surgical traumatic chylothoraces are usually self-evident based on the surgical field or procedure. However, lymphangiography with post-procedure CT scanning or lymphoscintigraphy may be used to identify the exact site of leakage, although the degree to which these procedures influence the course of therapy is controversial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/33\">",
"     33",
"    </a>",
"    ]. We typically perform lymphatic imaging when the diagnosis of thoracic duct tear is uncertain after pleural fluid analysis and chest computed tomography, when a chylothorax recurs after thoracic duct ligation, or when anomalous thoracic duct anatomy is suspected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/44\">",
"     44",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Lymphangiography is performed using bilateral localization of pedal lymphatics with a subcutaneous injection of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/7/1143?source=see_link\">",
"     methylene blue",
"    </a>",
"    , followed by a minor surgical procedure to cannulate the lymphatic vessel and inject Lipiodol contrast agent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. Conventional films and CT images (without intravenous contrast) are then obtained. Lymphangiography can identify areas of chyle leakage and lymphangiectasia in the majority of patients. As an example, in a series of 43 patients who underwent lymphangiography, the location of the leak was identified in 79 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Lymphangiography may occasionally be therapeutic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/47-49\">",
"     47-49",
"    </a>",
"    ]. As an example, in a case series of 43 patients, lymphangiography occluded lymphatic leaks in 70 percent of those with a lymphatic drainage volume less than 500",
"    <span class=\"nowrap\">",
"     mL/day",
"    </span>",
"    and in 35 percent of those with leakage higher than 500",
"    <span class=\"nowrap\">",
"     mL/day",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/47\">",
"     47",
"    </a>",
"    ]. In contrast, a separate series found cessation of chyle leak in only 11 of 20 patients who underwent lymphangiography for postoperative chylothorax [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Lymphoscintigraphy is usually performed by injection of technetium99-labelled human serum albumin-diethylenetriaminepentaacetic acid (HSA-DTPA) into the subcutaneous regions of the dorsum pedis bilaterally. Sequential, anterior and posterior views of the thorax are obtained with a single photon emission computed tomography combined with integrated low-dose CT",
"    <span class=\"nowrap\">",
"     (SPECT/CT)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/50\">",
"     50",
"    </a>",
"    ]. Radiolocalization using lymphoscintigraphy has shown good correlation with lymphangiography and with surgical localization of chyle leaks following surgery, superior vena cava thrombosis, and childbirth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37192/abstract/50-54\">",
"     50-54",
"    </a>",
"    ]. As lymphoscintigraphy is less invasive than lymphangiography, it may be used before lymphangiography as a diagnostic tool in centers where it is available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11897887\">",
"    <span class=\"h3\">",
"     Echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;When constrictive pericarditis is considered a potential cause of chylothorax, echocardiography is an essential diagnostic test. The evaluation of patients with suspected constrictive pericarditis is discussed separately (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/12/12490?source=see_link&amp;anchor=H13#H13\">",
"     \"Constrictive pericarditis\", section on 'Echocardiography'",
"    </a>",
"    .).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29696397\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A chylothorax occurs when lymph fluid from the thoracic duct or its tributaries accumulates in the pleural space. Chylous ascitic fluid can also flow into the pleural space. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Chylothorax versus cholesterol effusion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The etiologies of chylothorax can be categorized as nontraumatic or traumatic (",
"      <a class=\"graphic graphic_table graphicRef61456 \" href=\"mobipreview.htm?32/27/33212\">",
"       table 1",
"      </a>",
"      ). Malignancy is the leading cause of nontraumatic chylothorax. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Etiology of chylothorax'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chyle (lymphatic fluid of intestinal origin) has a high content of triglycerides in the form of chylomicrons, which produce the milky, opalescent appearance of lymphatic fluid. This milky appearance may clear during a fast and rapidly return after ingestion of dietary fat. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Chyle composition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with a chylothorax usually present with the typical signs and symptoms induced by the mechanical effects of a pleural effusion. Patients with nontraumatic chylothoraces frequently experience a gradual onset of decreased exercise tolerance, dyspnea, a heavy feeling in the chest, and fatigue. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of chylothorax is based on the pleural fluid triglyceride level (",
"      <a class=\"graphic graphic_figure graphicRef86646 \" href=\"mobipreview.htm?3/61/4062\">",
"       figure 2",
"      </a>",
"      ). A triglyceride concentration greater than 110",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (1.24",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      strongly supports the diagnosis. For values less than 110",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (1.24",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      a lipoprotein analysis of the pleural fluid is obtained to assess for chylomicrons if a chylothorax remains suspected. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Pleural fluid analysis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chylothorax generally results in an exudative pleural effusion; however, transudative chylothorax has been reported in small numbers of patients with amyloidosis, cirrhosis, nephrotic syndrome, superior vena cava obstruction, heart failure, and chylous ascites that has crossed the diaphragm into the pleural space. (See",
"      <a class=\"local\" href=\"#H229728\">",
"       'Other chemistries'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Computed tomography (CT) of the thorax and abdomen is typically performed in most patients with a chylothorax, looking for mediastinal and retroperitoneal lymphadenopathy or masses, and also lung parenchymal diseases that may provide a clue to the etiology (eg, lymphangioleiomyomatosis). (See",
"      <a class=\"local\" href=\"#H183969561\">",
"       'Imaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We typically perform lymphatic imaging when the diagnosis of thoracic duct tear is uncertain after pleural fluid analysis and chest computed tomography, when a chylothorax recurs after thoracic duct ligation, or when anomalous thoracic duct anatomy is suspected. (See",
"      <a class=\"local\" href=\"#H183969561\">",
"       'Imaging'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/1\">",
"      Roy, PH, Carr, DT, Payne, WS. The problem of chylothorax. Mayo Clin Proc 1967; 42:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/2\">",
"      Hillerdal G. Chylothorax and pseudochylothorax. Eur Respir J 1997; 10:1157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/3\">",
"      Garcia-Zamalloa A, Ruiz-Irastorza G, Aguayo FJ, Gurrutxaga N. Pseudochylothorax. Report of 2 cases and review of the literature. Medicine (Baltimore) 1999; 78:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/4\">",
"      Agrawal V, Sahn SA. Lipid pleural effusions. Am J Med Sci 2008; 335:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/5\">",
"      COE JE, AIKAWA JK. Cholesterol pleural effusion. Report of 2 cases studied with isotopic techniques and review of the world literature. Arch Intern Med 1961; 108:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/6\">",
"      Hillerdal G. Chyliform (cholesterol) pleural effusion. Chest 1985; 88:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/7\">",
"      Valentine VG, Raffin TA. The management of chylothorax. Chest 1992; 102:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/8\">",
"      Doerr CH, Miller DL, Ryu JH. Chylothorax. Semin Respir Crit Care Med 2001; 22:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/9\">",
"      Weidner WA, Steiner RM. Roentgenographic demonstration of intrapulmonary and pleural lymphatics during lymphangiography. Radiology 1971; 100:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/10\">",
"      Macfarlane JR, Holman CW. Chylothorax. Am Rev Respir Dis 1972; 105:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/11\">",
"      Doerr CH, Allen MS, Nichols FC 3rd, Ryu JH. Etiology of chylothorax in 203 patients. Mayo Clin Proc 2005; 80:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/12\">",
"      Hooper C, Lee YC, Maskell N, BTS Pleural Guideline Group. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 Suppl 2:ii4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/13\">",
"      McWilliams A, Gabbay E. Chylothorax occurring 23 years post-irradiation: literature review and management strategies. Respirology 2000; 5:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/14\">",
"      Lee YC, Tribe AE, Musk AW. Chylothorax from radiation-induced mediastinal fibrosis. Aust N Z J Med 1998; 28:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/15\">",
"      Blankenship ME, Rowlett J, Timby JW, et al. Giant lymph node hyperplasia (Castleman's disease) presenting with chylous pleural effusion. Chest 1997; 112:1132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/16\">",
"      Ten Hoor T, Hewan-Lowe K, Miller JI, Moss M. A transitional variant of Castleman's disease presenting as a chylous pleural effusion. Chest 1999; 115:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/17\">",
"      Diaz-Guzman E, Culver DA, Stoller JK. Transudative chylothorax: report of two cases and review of the literature. Lung 2005; 183:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/18\">",
"      Maldonado F, Tazelaar HD, Wang CW, Ryu JH. Yellow nail syndrome: analysis of 41 consecutive patients. Chest 2008; 134:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/19\">",
"      Ryu JH, Doerr CH, Fisher SD, et al. Chylothorax in lymphangioleiomyomatosis. Chest 2003; 123:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/20\">",
"      Fernandez FG, Denlinger CE, Patterson GA, et al. Massive bilateral chylothoraces complicating mediastinal granulomatous disease. Ann Thorac Surg 2009; 88:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/21\">",
"      Karapolat S, Sanli A, Onen A. Chylothorax due to tuberculosis lymphadenopathy: report of a case. Surg Today 2008; 38:938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/22\">",
"      Tutor JD, Schoumacher RA, Chesney PJ. Chylothorax associated with histoplasmosis in a child. Pediatr Infect Dis J 2000; 19:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/23\">",
"      Kurekci E, Kaye R, Koehler M. Chylothorax and chylopericardium: a complication of a central venous catheter. J Pediatr 1998; 132:1064.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/24\">",
"      Ferguson MK, Little AG, Skinner DB. Current concepts in the management of postoperative chylothorax. Ann Thorac Surg 1985; 40:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/25\">",
"      Terzi A, Furlan G, Magnanelli G, et al. Chylothorax after pleuro-pulmonary surgery: a rare but unavoidable complication. Thorac Cardiovasc Surg 1994; 42:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/26\">",
"      Ziedalski TM, Raffin TA, Sze DY, et al. Chylothorax after heart/lung transplantation. J Heart Lung Transplant 2004; 23:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/27\">",
"      Zabeck H, Muley T, Dienemann H, Hoffmann H. Management of chylothorax in adults: when is surgery indicated? Thorac Cardiovasc Surg 2011; 59:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/28\">",
"      Johnson TJ, Jamous FG, Kooistra A, Zawada ET. Iatrogenic chylothorax due to pleural cavity extravasation of total parenteral nutrition in two adults receiving nutrition through a peripherally inserted central catheter. Hosp Pract (Minneap) 2010; 38:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/29\">",
"      Vincent RP, Barron JL, Mulleague L. Differential diagnosis of chylothorax in a patient on parenteral nutrition: a case report. Ann Clin Biochem 2010; 47:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/30\">",
"      Prakash, UBS. Chylothorax and pseudochylothorax. Eur Respir Mon 2002; 7:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/31\">",
"      Lim KG, Rosenow EC 3rd, Staats B, et al. Chyloptysis in adults: presentation, recognition, and differential diagnosis. Chest 2004; 125:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/32\">",
"      Sarsam MA, Rahman AN, Deiraniya AK. Postpneumonectomy chylothorax. Ann Thorac Surg 1994; 57:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/33\">",
"      Maldonado F, Cartin-Ceba R, Hawkins FJ, Ryu JH. Medical and surgical management of chylothorax and associated outcomes. Am J Med Sci 2010; 339:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/34\">",
"      Maldonado F, Hawkins FJ, Daniels CE, et al. Pleural fluid characteristics of chylothorax. Mayo Clin Proc 2009; 84:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/35\">",
"      Staats BA, Ellefson RD, Budahn LL, et al. The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin Proc 1980; 55:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/36\">",
"      Sassoon CS, Light RW. Chylothorax and pseudochylothorax. Clin Chest Med 1985; 6:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/37\">",
"      Huggins JT. Chylothorax and cholesterol pleural effusion. Semin Respir Crit Care Med 2010; 31:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/38\">",
"      McGrath EE, Blades Z, Anderson PB. Chylothorax: aetiology, diagnosis and therapeutic options. Respir Med 2010; 104:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/39\">",
"      Ryu JH, Tomassetti S, Maldonado F. Update on uncommon pleural effusions. Respirology 2011; 16:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/40\">",
"      Agrawal V, Doelken P, Sahn SA. Pleural fluid analysis in chylous pleural effusion. Chest 2008; 133:1436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/41\">",
"      Duntley P, Siever J, Korwes ML, et al. Vascular erosion by central venous catheters. Clinical features and outcome. Chest 1992; 101:1633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/42\">",
"      Park JG, Aubry MC, Godfrey JA, Midthun DE. Mediastinal lymphangioma: Mayo Clinic experience of 25 cases. Mayo Clin Proc 2006; 81:1197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/43\">",
"      Hunt JP, Wilson M, Buchmann LO. Chylothorax associated with substernal goiter treated with transcervical thyroidectomy. Thyroid 2011; 21:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/44\">",
"      Mine S, Udagawa H, Kinoshita Y, Makuuchi R. Post-esophagectomy chylous leakage from a duplicated left-sided thoracic duct ligated successfully with left-sided video-assisted thoracoscopic surgery. Interact Cardiovasc Thorac Surg 2008; 7:1186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/45\">",
"      Deso S, Ludwig B, Kabutey NK, et al. Lymphangiography in the diagnosis and localization of various chyle leaks. Cardiovasc Intervent Radiol 2012; 35:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/46\">",
"      Plotnik AN, Foley PT, Koukounaras J, Lyon SM. How I do it: Lymphangiography. J Med Imaging Radiat Oncol 2010; 54:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/47\">",
"      Alejandre-Lafont E, Krompiec C, Rau WS, Krombach GA. Effectiveness of therapeutic lymphography on lymphatic leakage. Acta Radiol 2011; 52:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/48\">",
"      Kos S, Haueisen H, Lachmund U, Roeren T. Lymphangiography: forgotten tool or rising star in the diagnosis and therapy of postoperative lymphatic vessel leakage. Cardiovasc Intervent Radiol 2007; 30:968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/49\">",
"      Matsumoto T, Yamagami T, Kato T, et al. The effectiveness of lymphangiography as a treatment method for various chyle leakages. Br J Radiol 2009; 82:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/50\">",
"      Momose M, Kawakami S, Koizumi T, et al. Lymphoscintigraphy using technetium-99m HSA-DTPA with SPECT/CT in chylothorax after childbirth. Radiat Med 2008; 26:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/51\">",
"      Suga K, Kume N, Hara A, et al. Abnormal lymphatic flow demonstrated by lymphoscintigraphy in chylothorax correlation with lymphography. Clin Nucl Med 1999; 24:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/52\">",
"      Ogi S, Fukumitsu N, Uchiyama M, Mori Y. A case of chylothorax diagnosed by lymphoscintigraphy using Tc-99m HSA-DTPA. Clin Nucl Med 2002; 27:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/53\">",
"      Stavngaard T, Mortensen J, Brenoe J, Svendsen LB. Lymphoscintigraphy using technetium-99m human serum albumin in chylothorax. Thorac Cardiovasc Surg 2002; 50:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37192/abstract/54\">",
"      Restrepo JM, Caride VJ. Lymphoscintigraphy and radionuclide venography in chylothorax. Clin Nucl Med 2004; 29:440.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6696 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-221.179.173.170-7B5B02C4AA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_20_37192=[""].join("\n");
var outline_f36_20_37192=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H29696397\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CHYLOTHORAX VERSUS CHOLESTEROL EFFUSION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ANATOMY OF THE THORACIC DUCT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CHYLE COMPOSITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      ETIOLOGY OF CHYLOTHORAX",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Nontraumatic causes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Traumatic causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H183969546\">",
"      EVALUATION AND DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6014926\">",
"      Laboratory testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Pleural fluid analysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H229690\">",
"      - Appearance",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11897784\">",
"      - Cell counts",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H229718\">",
"      - Lipid analysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H229728\">",
"      - Other chemistries",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H183969561\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10472842\">",
"      - Computed tomography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10472849\">",
"      - Lymphangiography and lymphoscintigraphy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11897887\">",
"      - Echocardiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29696397\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/6696\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6696|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?9/19/9525\" title=\"figure 1\">",
"      Anatomy of thoracic duct",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?3/61/4062\" title=\"figure 2\">",
"      Pleural fluid triglycerides in chylothorax",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6696|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?32/27/33212\" title=\"table 1\">",
"      Causes of chylothorax",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/31/1530?source=related_link\">",
"      An overview of amyloidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/51/6970?source=related_link\">",
"      Castleman's disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/2/19497?source=related_link\">",
"      Child abuse: Injuries of the thorax; abdomen; retroperitoneum; and pelvis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/10/168?source=related_link\">",
"      Chylous, bloody, and pancreatic ascites",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/25/21914?source=related_link\">",
"      Clinical manifestations and diagnosis of sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/61/27610?source=related_link\">",
"      Clinical presentation and diagnosis of non-Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/45/31448?source=related_link\">",
"      Clinical presentation, diagnosis and management of cholesterol effusions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/12/12490?source=related_link\">",
"      Constrictive pericarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/7/16505?source=related_link\">",
"      Diagnostic evaluation of a pleural effusion in adults: Initial testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/36/2632?source=related_link\">",
"      Diagnostic evaluation of pleural effusion in adults: Additional tests for undetermined etiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/23/12663?source=related_link\">",
"      Diagnostic thoracentesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/47/762?source=related_link\">",
"      Epidemiology, pathogenesis, clinical manifestations and diagnosis of Waldenstr&ouml;m macroglobulinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/29/43481?source=related_link\">",
"      Esophagectomy: Complications and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/6/99?source=related_link\">",
"      Heart-lung transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/56/21384?source=related_link\">",
"      Imaging of pleural effusions in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/32/31241?source=related_link\">",
"      Management of chylothorax",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/53/36695?source=related_link\">",
"      Mechanisms of pleural liquid accumulation in disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/37/34393?source=related_link\">",
"      Nonimmune hydrops fetalis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/21/16728?source=related_link\">",
"      Pleural effusions following cardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/27/23993?source=related_link\">",
"      Pleural effusions in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/50/3881?source=related_link\">",
"      Protein-losing gastroenteropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/30/4586?source=related_link\">",
"      Pulmonary lymphangioleiomyomatosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/36/32329?source=related_link\">",
"      Sequelae and complications of pneumonectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/22/32103?source=related_link\">",
"      The pleura in lung transplantation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_20_37193="Overview of the acute management of unstable angina and non-ST elevation myocardial infarction";
var content_f36_20_37193=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of the acute management of unstable angina and non-ST elevation myocardial infarction",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/20/37193/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/20/37193/contributors\">",
"     Jeffrey A Breall, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/20/37193/contributors\">",
"     Julian M Aroesty, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/20/37193/contributors\">",
"     Michael Simons, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/20/37193/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/20/37193/contributors\">",
"     Christopher P Cannon, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/20/37193/contributors\">",
"     James Hoekstra, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/20/37193/contributors\">",
"     Donald Cutlip, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/20/37193/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/20/37193/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/20/37193/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 11, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unstable angina (UA), acute non-ST elevation myocardial infarction (NSTEMI), and acute ST elevation myocardial infarction (STEMI) are the three presentations of acute coronary syndromes (ACS). The first step in the management of patients ACS is prompt recognition, since the beneficial effects of therapy are greatest when performed soon after hospital presentation. For patients presenting to the emergency department with chest pain suspicious for an ACS, the diagnosis of myocardial infarction can be confirmed by the ECG and serum cardiac biomarker elevation; the history is relied upon heavily to make the diagnosis of unstable angina. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/39/25209?source=see_link\">",
"     \"Criteria for the diagnosis of acute myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/43/15034?source=see_link\">",
"     \"Initial evaluation and management of suspected acute coronary syndrome in the emergency department\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Once the diagnosis of either UA or an acute NSTEMI is made, the acute management of the patient involves the simultaneous achievement of several goals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Relief of ischemic pain. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Initial medical therapy'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Assessment of the patient's hemodynamic status and correction of abnormalities. Hypertension and tachycardia, both of which will markedly increase myocardial oxygen consumption requirements, may be managed with beta blockers and intravenous",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/24/11656?source=see_link\">",
"       nitroglycerin",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      Estimation of risk (see",
"      <a class=\"local\" href=\"#H19\">",
"       'Early risk stratification'",
"      </a>",
"      below).",
"     </li>",
"     <li>",
"      Choice of a management strategy, ie, an early invasive strategy (with angiography and intent for revascularization with PCI or CABG as defined by the anatomy) versus a conservative strategy with medical therapy. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Immediate angiography and revascularization'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Initiation of antithrombotic therapy (including antiplatelet and anticoagulant therapies) to prevent further thrombosis of or embolism from an ulcerated plaque.",
"     </li>",
"     <li>",
"      Beta blocker therapy to prevent recurrent ischemia and life-threatening ventricular arrhythmias",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The acute management goals should be followed by the administration of different drugs that may improve the long-term prognosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/1\">",
"     1",
"    </a>",
"    ]. Some of these therapies include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Long-term antiplatelet therapy to reduce the risk of recurrent coronary artery thrombosis or, with PCI, coronary artery stent thrombosis",
"     </li>",
"     <li>",
"      Statins",
"     </li>",
"     <li>",
"      Long-term oral anticoagulation in the presence of left ventricular thrombus or chronic atrial fibrillation to prevent embolization",
"     </li>",
"     <li>",
"      Possible use of an angiotensin converting enzyme (ACE) inhibitor in patients at increased risk",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic will summarize",
"    <span class=\"nowrap\">",
"     emergent/early",
"    </span>",
"    management issues for patients with UA or acute NSTEMI and then direct the reader to a more detailed discussion in other topics. The management of the patient after a revascularization strategy has been chosen and carried out is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/33/44569?source=see_link\">",
"     \"Overview of the non-acute management of unstable angina and non-ST elevation myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The management of the patient with ST elevation MI or with a complication of an acute MI (eg, cardiogenic shock, mitral regurgitation, ventricular septal defect) is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/41/44697?source=see_link\">",
"     \"Overview of the acute management of ST elevation myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/37/35418?source=see_link\">",
"     \"Prognosis and treatment of cardiogenic shock complicating acute myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/19/39225?source=see_link\">",
"     \"Mechanical complications of acute myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/43/15034?source=see_link\">",
"     \"Initial evaluation and management of suspected acute coronary syndrome in the emergency department\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL PRINCIPLES",
"    </span>",
"    &nbsp;&mdash;&nbsp;An increasing number of centers use structured algorithms, checklists, or critical pathways to screen patients with a suspected ACS (",
"    <a class=\"graphic graphic_algorithm graphicRef52942 \" href=\"mobipreview.htm?18/37/19026\">",
"     algorithm 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/3-8\">",
"     3-8",
"    </a>",
"    ]. Many of these strategies combine diagnostic evaluation, such as electrocardiography and serum biomarkers, with therapeutic interventions, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , beta blockers, antithrombotic agents, and, in most patients, early coronary angiography and revascularization. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/43/15034?source=see_link\">",
"     \"Initial evaluation and management of suspected acute coronary syndrome in the emergency department\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Definitions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients considered to have angina, there are three presentations of angina that suggest an acute coronary syndrome (ACS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Rest angina, which is usually more than 20 minutes in duration",
"     </li>",
"     <li>",
"      New onset angina that markedly limits physical activity",
"     </li>",
"     <li>",
"      Increasing angina that is more frequent, longer in duration, or occurs with less exertion than previous angina",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    UA and NSTEMI differ primarily in whether the ischemia is severe enough to cause sufficient myocardial damage to release detectable quantities of a marker of myocardial injury (troponins):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      UA is considered to be present in patients with ischemic symptoms suggestive of an ACS and no elevation in troponins, with or without ECG changes indicative of ischemia (eg, ST segment depression or transient elevation or new T wave inversion).",
"     </li>",
"     <li>",
"      NSTEMI is considered to be present in patients having the same manifestations as those in UA, but in whom an elevation in troponins is present.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Since an elevation in troponins may not be detectable for hours after presentation, UA and NSTEMI are frequently indistinguishable at initial evaluation. As a consequence, initial management is the same for these two syndromes. For this reason, and because the pathogenetic mechanisms of the two conditions are similar, they are often considered together. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/53/28505?source=see_link\">",
"     \"Classification of unstable angina and non-ST elevation myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Elderly patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is estimated that 60 to 65 percent of MIs occur in patients &ge;65 years of age and 33 percent occur in patients &ge;75 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. In addition, as many as 80 percent of all deaths related to MI occur in persons &ge;65 years of age.",
"   </p>",
"   <p>",
"    Although patients age 75 and older have been underrepresented in clinical trials of ACS, the following observations concerning acute MI in older adults compared to younger patients are generally accepted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/11\">",
"     11",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Elderly patients are more likely to have an NSTEMI rather than an STEMI.",
"     </li>",
"     <li>",
"      Elderly patients more frequently have an atypical presentation, including silent or unrecognized MI due to presenting symptoms of syncope, weakness, or confusion (delirium) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/11,12\">",
"       11,12",
"      </a>",
"      ]. Delays in diagnosis have been well-documented and often lead to delays in therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients &ge;75 years of age have a higher in-hospital mortality (19 versus 5 percent in one series) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/13\">",
"       13",
"      </a>",
"      ]. Both bleeding and recurrent MI are also more frequent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/11\">",
"       11",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Importance of dosing'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Elderly patients are more likely to have heart failure associated with the MI (40 versus 14 percent in one report), the risk for which increases progressively in each successive age group from 36 percent in those 65 to 69 years of age to 65 percent in those &ge;85 years of age [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some of the worse outcomes after acute MI probably result from comorbidities in elderly patients, but also can be attributed in part to a lower likelihood of receiving potentially beneficial therapies due to concerns about toxicity. Therapies such as beta blockers, percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG) are all utilized to a lesser degree in elderly patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/13-15\">",
"     13-15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A retrospective review of almost 57,000 patients with a non-ST elevation acute coronary syndrome found that, after adjustment, patients (including those &ge;75 years of age) who received more recommended therapies had lower in-hospital mortality rates than those who did not [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/16\">",
"     16",
"    </a>",
"    ]. Thus, although concern about risks and side effects is appropriate and it is not clear that adjustment accounted for all risk factors, older age alone should not be an indication to withhold recommended therapy.",
"   </p>",
"   <p>",
"    The 2007",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines recommended that elderly patients (defined as greater than 75 years of age) with unstable angina pectoris and NSTEMI should receive the same treatment as younger patients with the following cautions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The patient's general health, comorbidities, cognitive status, and life expectancy should be taken into account.",
"     </li>",
"     <li>",
"      Increased sensitivity to hypotension-inducing drugs and possible altered drug pharmacokinetics should be considered. Calculation of the creatinine clearance is recommended for all patients &ge;75 years of age at the time of initial care [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/11\">",
"       11",
"      </a>",
"      ]. This calculation requires a stable serum creatinine concentration. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/45/36570?source=see_link&amp;anchor=H20658806#H20658806\">",
"       \"Assessment of kidney function\", section on 'Assessment of GFR'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Intensive medical and interventional management can be undertaken with close monitoring for adverse effects.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Information of particular relevance to older adults will be mentioned throughout the remainder of this topic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Cocaine associated myocardial infarction",
"    </span>",
"    &nbsp;&mdash;&nbsp;MI is a well-described complication among patients presenting with cocaine-induced ischemic symptoms. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/39/39545?source=see_link&amp;anchor=H18#H18\">",
"     \"Evaluation and management of the cardiovascular complications of cocaine abuse\", section on 'Reperfusion and revascularization'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We agree with the 2008 American Heart Association scientific statement on the Management of cocaine-associated chest pain and myocardial infarction, which states that these patients should be managed in a manner similar to other ACS patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following two points were also made:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Benzodiazepines should be administered early",
"     </li>",
"     <li>",
"      Beta blockers should not be used in the setting of acute cocaine intoxication with chest pain due to the possibility of exacerbation of coronary artery vasoconstriction",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     INITIAL MEDICAL THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with UA or NSTEMI should be treated with an early medical regimen similar to that used in a STEMI with one exception: there is no evidence of benefit (and possible harm) from fibrinolysis. Initial therapy, which should be instituted within 20 minutes of presentation, is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/43/15034?source=see_link&amp;anchor=H3#H3\">",
"     \"Initial evaluation and management of suspected acute coronary syndrome in the emergency department\", section on 'Immediate ED interventions'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Drug metabolism is more likely to be reduced in elderly patients, particularly with regard to drugs that are excreted by the kidney. Dose adjustment is necessary with GP",
"    <span class=\"nowrap\">",
"     IIb/IIIa",
"    </span>",
"    inhibitors and unfractionated or low molecular weight",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    , but not with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/9/34969?source=see_link\">",
"     clopidogrel",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Elderly patients'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Anti-ischemic and analgesic therapy",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Oxygen",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend supplemental oxygen for patients with an arterial saturation less than 90 percent, patients in respiratory distress, or those with other high risk features for hypoxemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The role of supplemental oxygen in patients without hypoxia has not been well-studied. A 2010 Cochrane review evaluated three trials of 387 patients with presumed myocardial infarction (MI) who were randomly assigned to supplemental oxygen or room air. Enrolled patients were either hypoxic and normoxic. The study found no significant difference in mortality (pooled relative risk 2.88, [95% CI 0.88-9.39] in an intention-to-treat analysis and 3.03, [95% CI 0.93-9.83] among those with confirmed MI). No subgroup analysis was performed on those with normoxia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The suggestion of harm with supplemental oxygen found in this Cochrane review is of concern, particularly in patients with normoxia, as a pathophysiologic basis for such harm has been articulated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/19\">",
"     19",
"    </a>",
"    ]. Hyperoxia, which might occur with the administration of oxygen to normoxic individuals, has been shown to have a direct vasoconstrictor effect on the coronary arteries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Until better evidence to support the use of supplemental oxygen in normoxic patients with acute MI is available, we suggest (a weak recommendation) its use.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Nitroglycerin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sublingual",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/24/11656?source=see_link\">",
"     nitroglycerin",
"    </a>",
"    is administered to patients presenting with ischemic type chest pain, followed by intravenous nitroglycerin in patients with persistent pain after three sublingual nitroglycerin tablets, hypertension, or heart failure. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/63/24566?source=see_link\">",
"     \"Nitrates in the management of acute coronary syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Nitrates must be used with caution or avoided in settings in which hypotension is likely or could result in serious hemodynamic decompensation, such as right ventricular infarction or severe aortic stenosis. In addition, nitrates are contraindicated in patients who have taken a phosphodiesterase inhibitor for erectile dysfunction within the previous 24 hours. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/15/8442?source=see_link\">",
"     \"Sexual activity in patients with heart disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/57/922?source=see_link&amp;anchor=H12#H12\">",
"     \"Right ventricular myocardial infarction\", section on 'Optimization of right ventricular preload'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Morphine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intravenous",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"     morphine sulfate",
"    </a>",
"    at an initial dose of 2 to 4 mg, with increments of 2 to 8 mg repeated at 5 to 15 minute intervals, should be given for the relief of chest pain or anxiety.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Beta blockers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Controlled trials have repeatedly documented the beneficial effects of beta blockers in patients with acute myocardial infarction; however, there have been no randomized trials specifically addressing the efficacy of these drugs in non-ST elevation ACS. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/53/11098?source=see_link&amp;anchor=H23#H23\">",
"     \"Beta blockers in the management of acute coronary syndrome\", section on 'Summary and recommendations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Nevertheless, given the proven efficacy in unselected patients with an acute MI and the absence of harm in NSTEMI or UA, the 2007",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines recommended that beta blocker therapy should be administered universally to all patients without contraindications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/1\">",
"     1",
"    </a>",
"    ]. Similar recommendations were made by a 2004 task force of the European Society of Cardiology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In our view, treatment should include early use of intravenous beta blockade in patients without contraindications who have ongoing chest pain, hypertension, or tachycardia not caused by heart failure. This approach is supported by the 2007 AHA scientific statement on hypertension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/21\">",
"     21",
"    </a>",
"    ]. A cardioselective agent (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39417?source=see_link\">",
"     metoprolol",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/46/30440?source=see_link\">",
"     atenolol",
"    </a>",
"    ) is preferred.",
"   </p>",
"   <p>",
"    However, based upon the results of the",
"    <span class=\"nowrap\">",
"     COMMIT/CCS2",
"    </span>",
"    trial, the largest placebo-controlled trial ever performed with beta blockers in acute MI, it seems reasonable to defer intravenous beta blockers in patients who are hemodynamically compromised in whom mortality may actually be increased by such therapy. Once the patient is stable, an oral beta blocker can be started with gradual uptitration to the maintenance doses cited below. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/53/11098?source=see_link&amp;anchor=H12#H12\">",
"     \"Beta blockers in the management of acute coronary syndrome\", section on 'Early administration'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12643985\">",
"    <span class=\"h3\">",
"     Statin therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Statin therapy should be instituted prior to hospital discharge, with some data supporting initiation at the time of diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/1\">",
"     1",
"    </a>",
"    ]. We recommend therapy with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/37/35417?source=see_link\">",
"     atorvastatin",
"    </a>",
"    80",
"    <span class=\"nowrap\">",
"     mg/day,",
"    </span>",
"    which was used in the PROVE IT-TIMI 22 and MIRACL trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. Among patients who were previously treated with a different statin regimen, we suggest switching to atorvastatin 80",
"    <span class=\"nowrap\">",
"     mg/day.",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/55/33656?source=see_link&amp;anchor=H9#H9\">",
"     \"Cholesterol lowering after an acute coronary syndrome\", section on 'Continuation of prior statin therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Initial intensive statin therapy, rather than gradual dose titration upward, is recommended because of the suggestion of benefit in the PROVE IT-TIMI 22 trial within 30 days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/24\">",
"     24",
"    </a>",
"    ], an interval before the first serum cholesterol measurement on therapy would usually be obtained. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/55/33656?source=see_link\">",
"     \"Cholesterol lowering after an acute coronary syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Based on these recommendations, most patients should have a lipid profile performed early in their hospitalization, although some patients may have had recent outpatient testing. In the event that testing is not performed early after an ACS, values obtained up to four days after the event may represent baseline values. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/31/31222?source=see_link&amp;anchor=H24362763#H24362763\">",
"     \"Measurement of serum lipids and lipoproteins\", section on 'After an ACS'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Evaluation of the response to statin therapy after an acute coronary syndrome should be deferred for two months, since acute phase responses and perhaps other factors can transiently lower LDL-cholesterol by 40 to 50 percent and thus, in some patients, cause spuriously normal-appearing levels following an acute coronary syndrome. However, the magnitude of this effect, at least soon after hospitalization, appears to be less with current therapies that limit the degree of myocardial injury, such as percutaneous coronary intervention or fibrinolytic therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/31/31222?source=see_link&amp;anchor=H24362763#H24362763\">",
"     \"Measurement of serum lipids and lipoproteins\", section on 'After an ACS'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/55/33656?source=see_link\">",
"     \"Cholesterol lowering after an acute coronary syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The long-term LDL-cholesterol goal is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/59/3002?source=see_link\">",
"     \"Intensity of lipid lowering therapy in secondary prevention of coronary heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Antithrombotic therapy",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Antiplatelet therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the absence of an absolute contraindication, antiplatelet therapy with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    and a platelet P2Y12 receptor blocker is indicated in",
"    <strong>",
"     all",
"    </strong>",
"    patients with a non-ST elevation ACS&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/20/39242?source=see_link\">",
"     \"Antiplatelet agents in acute non-ST elevation acute coronary syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Anticoagulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;For all patients with non-ST elevation ACS, we recommend anticoagulant therapy as soon as possible after the diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/2/5162?source=see_link\">",
"     \"Anticoagulant therapy in non-ST elevation acute coronary syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Importance of dosing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Excessive dosing of antithrombotic and antiplatelet agents is common and associated with an increase in bleeding risk. This issue is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/2/5162?source=see_link&amp;anchor=H100954534#H100954534\">",
"     \"Anticoagulant therapy in non-ST elevation acute coronary syndromes\", section on 'Anticoagulant regimens'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Potassium and magnesium",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although there are no clinical trials documenting the benefits of electrolyte replacement in acute MI, the",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines recommend maintaining the serum potassium concentration above 4.0",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    and a serum magnesium concentration above 2.0",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    (2.4",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    or 1",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. Much of the evidence for this recommendation was derived from studies before the routine use of beta blocker and the use of reperfusion in many patients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/10/30890?source=see_link&amp;anchor=H24#H24\">",
"     \"Clinical features and treatment of ventricular arrhythmias during acute myocardial infarction\", section on 'Ventricular fibrillation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A 2012 retrospective cohort study found that for patients with acute MI the lowest mortality was observed in those with post-admission serum potassium values between 3.5 and &lt;4.5",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/52/35658?source=see_link&amp;anchor=H458465082#H458465082\">",
"     \"Risk stratification for cardiac events after acute ST elevation myocardial infarction\", section on 'Serum potassium'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We suggest that the serum potassium fall within the range of 3.5 to 4.5",
"    <span class=\"nowrap\">",
"     meq/L.",
"    </span>",
"    Some of our reviewers prefer a tighter range of 4.0 to 4.5",
"    <span class=\"nowrap\">",
"     meq/L.",
"    </span>",
"    It may be difficult to lower the potassium below 4.5",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    in some patients, such as those with chronic kidney disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Non-steroidal antiinflammatory drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonsteroidal antiinflammatory drugs (except",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    ) should be discontinued immediately due to an increased risk of cardiovascular events associated with their use. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/4/24648?source=see_link\">",
"     \"Nonselective NSAIDs: Adverse cardiovascular effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1151892438\">",
"    <span class=\"h2\">",
"     Intravenous glucose-insulin-potassium",
"    </span>",
"    &nbsp;&mdash;&nbsp;We do not recommend the use of intravenous glucose-insulin-potassium (GIK) to improve outcomes in patients with suspected or diagnosed acute MI. Much of the available evidence comes from studies of patients with ST-elevation MI. The discussion of the potential use of GIK in these patients is found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/41/44697?source=see_link&amp;anchor=H1143773188#H1143773188\">",
"     \"Overview of the acute management of ST elevation myocardial infarction\", section on 'Intravenous glucose-insulin-potassium'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The IMMEDIATE trial randomly assigned 871 patients with suspected acute coronary syndromes (approximately 60 percent without ST-elevation on the presenting electrocardiogram) to intravenous GIK or identical-appearing 5 percent glucose placebo, which was administered by paramedics in the out-of-hospital setting and continued for 12 hours [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/29\">",
"     29",
"    </a>",
"    ]. There was no difference in the rate of progression to MI (as measured by biomarkers and ECG evidence) at 24 hours or the rate of death at 30 days among patients who received GIK compared to those who received placebo (48.7 versus 52.6 percent; odds ratio 0.88, 95% CI 0.66-1.13 and 4.4 versus 6.1 percent; odds ratio 0.72, 95% CI 0.40-1.29, respectively).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     ARRHYTHMIA MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both atrial and ventricular arrhythmias can be seen during and after the acute phase of an NSTEMI. These include atrial fibrillation or flutter, which can cause symptomatic hypoperfusion due to a rapid rate, and life-threatening ventricular tachycardia or ventricular fibrillation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/14/16615?source=see_link\">",
"     \"Supraventricular arrhythmias after myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/10/30890?source=see_link\">",
"     \"Clinical features and treatment of ventricular arrhythmias during acute myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Prophylactic intravenous or intramuscular",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    to prevent",
"    <span class=\"nowrap\">",
"     VT/VF",
"    </span>",
"    in the acute MI patient is",
"    <strong>",
"     not",
"    </strong>",
"    recommended. Recommended prophylactic measures include early administration of a beta blocker and treatment of hypokalemia and hypomagnesemia. Treatment of ventricular tachyarrhythmias in the setting of acute MI is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/10/30890?source=see_link\">",
"     \"Clinical features and treatment of ventricular arrhythmias during acute myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     EARLY RISK STRATIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early risk stratification in patients with ACS is essential to identify those patients at highest risk for further cardiac events who may benefit from a more aggressive therapeutic approach [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/1,30,31\">",
"     1,30,31",
"    </a>",
"    ]. Clinical trials have identified a number of factors predicting high risk and a benefit from an early invasive strategy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/32-36\">",
"     32-36",
"    </a>",
"    ]. These include the presence and extent of ST segment depression, elevated cardiac biomarkers, evidence of hemodynamic instability, and persistent chest pain despite appropriate medical therapy. These variables have been used to create risk scores such as TIMI, GRACE, and PURSUIT. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/43/2746?source=see_link\">",
"     \"Risk stratification after unstable angina or non-ST elevation myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/36/29257?source=see_link\">",
"     \"Trials of conservative versus early invasive therapy in unstable angina and non-ST elevation myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It should be noted, however, that individual factors in the seven-point TIMI risk score may carry more risk than others, or be more specific for acute coronary syndrome than others. As an example, serum troponin elevation and ST segment depression individually are markers of high risk, regardless of the other TIMI risk factors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     TIMI risk score",
"    </span>",
"    &nbsp;&mdash;&nbsp;Analysis of data from the TIMI 11B and ESSENCE trials found that seven variables at presentation were independently predictive of outcome in patients with unstable angina or an NSTEMI; a value of one was assigned when a factor was present and 0 when it was absent (",
"    <a class=\"calc calc_professional\" href=\"mobipreview.htm?5/34/5665?source=see_link\">",
"     calculator 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/37\">",
"     37",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Age &ge;65 years",
"     </li>",
"     <li>",
"      Presence of at least three risk factors for CHD (hypertension, diabetes, dyslipidemia, smoking, or positive family history of early MI)",
"     </li>",
"     <li>",
"      Prior coronary stenosis of &ge;50 percent",
"     </li>",
"     <li>",
"      Presence of ST segment deviation on admission ECG",
"     </li>",
"     <li>",
"      At least two anginal episodes in prior 24 hours",
"     </li>",
"     <li>",
"      Elevated serum cardiac biomarkers",
"     </li>",
"     <li>",
"      Use of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      in prior seven days (which is probably a marker for more severe coronary disease) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/38\">",
"       38",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients are considered to be at low risk with a score of 0 to 2; intermediate risk with a score of 3 to 4; and high risk with a score of 5 to 7 (",
"    <a class=\"graphic graphic_figure graphicRef67473 \" href=\"mobipreview.htm?30/55/31614\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     EARLY REPERFUSION AND REVASCULARIZATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Avoidance of fibrinolysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prospective trials have demonstrated that fibrinolytic therapy is not beneficial in patients with a non-ST elevation ACS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/1,32,39\">",
"     1,32,39",
"    </a>",
"    ]. The",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    and ACCP recommend",
"    <strong>",
"     against",
"    </strong>",
"    the routine use of fibrinolytic agents in patients with a non-ST elevation ACS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/57/22421?source=see_link\">",
"     \"Fibrinolytic (thrombolytic) agents in unstable angina and acute non-ST elevation myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Immediate angiography and revascularization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who have a non-ST elevation ACS and one or more of the following characteristics are at extremely high risk of an adverse cardiovascular event in the short term:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hemodynamic instability or cardiogenic shock",
"     </li>",
"     <li>",
"      Severe left ventricular dysfunction or heart failure",
"     </li>",
"     <li>",
"      Recurrent or persistent rest angina despite intensive medical therapy",
"     </li>",
"     <li>",
"      New or worsening mitral regurgitation or new ventricular septal defect",
"     </li>",
"     <li>",
"      Sustained ventricular arrhythmias",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    We recommend that patients with any of these five characteristics be referred for",
"    <strong>",
"     immediate",
"    </strong>",
"    coronary arteriography and revascularization.",
"   </p>",
"   <p>",
"    For those without one of the above extremely high risk characteristics, randomized trials have shown benefit of an early invasive approach in high-risk ACS. While the optimal timing is uncertain, the majority of patients undergo coronary revascularization early (ie, within 24 hours). This early timing was shown to be of clear benefit in high-risk patients in the TIMACS trial and subgroup analyses of major trials support this approach in elderly patients as well as younger patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/1/29722?source=see_link&amp;anchor=H18#H18\">",
"     \"Coronary arteriography and revascularization for unstable angina or non-ST elevation acute myocardial infarction\", section on 'Timing of early intervention'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A widely used predictive model used to guide invasive versus conservative strategy is the TIMI risk score, which is based upon seven variables available at presentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/37\">",
"     37",
"    </a>",
"    ]. Patients with high-risk TIMI scores of five to seven, as well as intermediate-risk TIMI scores of three to four, benefited from early invasive strategy in the TACTICS-TIMI 18 trial. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Early risk stratification'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/1/29722?source=see_link&amp;anchor=H7#H7\">",
"     \"Coronary arteriography and revascularization for unstable angina or non-ST elevation acute myocardial infarction\", section on 'Early risk assessment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    High risk criteria have also been defined by the 2007",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines on unstable angina and non-ST elevation MI and the 2005 European Society of Cardiology guidelines as cardiac biomarker elevations, ST segment depression, recurrent angina, hemodynamic instability, sustained",
"    <span class=\"nowrap\">",
"     VT/VF,",
"    </span>",
"    prior PCI within the prior six months or CABG, and diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/1,42\">",
"     1,42",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/1/29722?source=see_link\">",
"     \"Coronary arteriography and revascularization for unstable angina or non-ST elevation acute myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The choice of revascularization procedure after angiography depends upon the location and extent of disease. Among patients with an appropriate lesion, PCI is most often performed, but coronary artery bypass grafting (CABG) is usually preferred for the treatment of patients with left main or left main equivalent disease, or three or two vessel disease involving the left anterior descending artery with left ventricular dysfunction or treated diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/43\">",
"     43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/1/29722?source=see_link&amp;anchor=H23#H23\">",
"     \"Coronary arteriography and revascularization for unstable angina or non-ST elevation acute myocardial infarction\", section on 'PCI versus CABG'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     MI with normal coronary arteries",
"    </span>",
"    &nbsp;&mdash;&nbsp;In clinical trials, 9 to 14 percent of patients with a non-ST elevation ACS who undergo early angiography have no significant coronary stenosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/33,34,44-46\">",
"     33,34,44-46",
"    </a>",
"    ]. Possible mechanisms include rapid clot lysis, vasospasm, myocarditis, and coronary microvascular disease. Such patients have a much better short-term prognosis than those with a culprit lesion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37193/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/53/28505?source=see_link&amp;anchor=H10#H10\">",
"     \"Classification of unstable angina and non-ST elevation myocardial infarction\", section on 'Absence of significant coronary disease'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/39/3706?source=see_link\">",
"     \"Variant angina\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/39/39545?source=see_link\">",
"     \"Evaluation and management of the cardiovascular complications of cocaine abuse\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/42/5802?source=see_link&amp;anchor=H4#H4\">",
"     \"Cardiac syndrome X: Angina pectoris with normal coronary arteries\", section on 'Acute coronary syndrome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/16/26889?source=see_link&amp;anchor=H16#H16\">",
"     \"Clinical manifestations and diagnosis of myocarditis in adults\", section on 'Electrocardiogram'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unstable angina and acute non-ST elevation myocardial infarction (NSTEMI) are medical emergencies requiring the simultaneous application of multiple therapies. After the emergent period, other therapies may need to be started. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/33/44569?source=see_link\">",
"     \"Overview of the non-acute management of unstable angina and non-ST elevation myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Women and men should be managed similarly. Other patients, such as the elderly and those with either cocaine associated MI, are managed somewhat differently. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'General principles'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The initial assessment and therapy of unstable angina and NSTEMI is summarized in table form (",
"    <a class=\"graphic graphic_table graphicRef75032 \" href=\"mobipreview.htm?33/25/34206\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Anderson J, Adams C, Antman E, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, American College or Physicians, Society for Academic Emergency Medicine, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2007; 50:e1 www.acc.org/qualityandscience/clinical/statements.htm (Accessed on September 18, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/2\">",
"      Harrington RA, Becker RC, Cannon CP, et al. Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133:670S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/3\">",
"      Tatum JL, Jesse RL, Kontos MC, et al. Comprehensive strategy for the evaluation and triage of the chest pain patient. Ann Emerg Med 1997; 29:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/4\">",
"      Ornato JP. Chest pain emergency centers: improving acute myocardial infarction care. Clin Cardiol 1999; 22:IV3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/5\">",
"      Gibler WB. Evaluation of chest pain in the emergency department. Ann Intern Med 1995; 123:315; author reply 317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/6\">",
"      Cannon CP, Hand MH, Bahr R, et al. Critical pathways for management of patients with acute coronary syndromes: an assessment by the National Heart Attack Alert Program. Am Heart J 2002; 143:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/7\">",
"      Bassan R, Pimenta L, Scofano M, et al. Probability stratification and systematic diagnostic approach for chest pain patients in the emergency department. Crit Pathw Cardiol 2004; 3:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/8\">",
"      Herzog E, Saint-Jacques H, Rozanski A. The PAIN pathway as a tool to bridge the gap between evidence and management of acute coronary syndrome. Crit Pathw Cardiol 2004; 3:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/9\">",
"      Goldberg RJ, McCormick D, Gurwitz JH, et al. Age-related trends in short- and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975-1995). Am J Cardiol 1998; 82:1311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/10\">",
"      Roger VL, Jacobsen SJ, Weston SA, et al. Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994. Ann Intern Med 2002; 136:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/11\">",
"      Alexander KP, Newby LK, Cannon CP, et al. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation 2007; 115:2549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/12\">",
"      Bayer AJ, Chadha JS, Farag RR, Pathy MS. Changing presentation of myocardial infarction with increasing old age. J Am Geriatr Soc 1986; 34:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/13\">",
"      Paul SD, O'Gara PT, Mahjoub ZA, et al. Geriatric patients with acute myocardial infarction: Cardiac risk factor profiles, presentation, thrombolysis, coronary interventions, and prognosis. Am Heart J 1996; 131:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/14\">",
"      Mehta RH, Rathore SS, Radford MJ, et al. Acute myocardial infarction in the elderly: differences by age. J Am Coll Cardiol 2001; 38:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/15\">",
"      Stone PH, Thompson B, Anderson HV, et al. Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. JAMA 1996; 275:1104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/16\">",
"      Alexander KP, Roe MT, Chen AY, et al. Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 2005; 46:1479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/17\">",
"      McCord J, Jneid H, Hollander JE, et al. Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Circulation 2008; 117:1897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/18\">",
"      Cabello JB, Burls A, Emparanza JI, et al. Oxygen therapy for acute myocardial infarction. Cochrane Database Syst Rev 2010; :CD007160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/19\">",
"      Moradkhan R, Sinoway LI. Revisiting the role of oxygen therapy in cardiac patients. J Am Coll Cardiol 2010; 56:1013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/20\">",
"      L&oacute;pez-Send&oacute;n J, Swedberg K, McMurray J, et al. Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J 2004; 25:1341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/21\">",
"      Rosendorff C, Black HR, Cannon CP, et al. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 2007; 115:2761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/22\">",
"      Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350:1495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/23\">",
"      Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001; 285:1711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/24\">",
"      Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/25\">",
"      Pitt B, Loscalzo J, Ycas J, Raichlen JS. Lipid levels after acute coronary syndromes. J Am Coll Cardiol 2008; 51:1440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/26\">",
"      Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004; 110:e82.",
"     </a>",
"    </li>",
"    <li>",
"     www.acc.org/qualityandscience/clinical/statements.htm (Accessed on September 18, 2007). www.acc.org/qualityandscience/clinical/statements.htm (Accessed on September 18, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/28\">",
"      Goyal A, Spertus JA, Gosch K, et al. Serum potassium levels and mortality in acute myocardial infarction. JAMA 2012; 307:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/29\">",
"      Selker HP, Beshansky JR, Sheehan PR, et al. Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial. JAMA 2012; 307:1925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/30\">",
"      Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 2000; 21:1406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/31\">",
"      Mehta SR, Cannon CP, Fox KA, et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA 2005; 293:2908.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/32\">",
"      Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation 1994; 89:1545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/33\">",
"      Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 344:1879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/34\">",
"      Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet 1999; 354:708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/35\">",
"      Lagerqvist B, S&auml;fstr&ouml;m K, St&aring;hle E, et al. Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? FRISC II Study Group Investigators. J Am Coll Cardiol 2001; 38:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/36\">",
"      Wallentin L, Lagerqvist B, Husted S, et al. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease. Lancet 2000; 356:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/37\">",
"      Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000; 284:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/38\">",
"      Borzak S, Cannon CP, Kraft PL, et al. Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia. Am J Cardiol 1998; 81:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/39\">",
"      Anderson HV, Cannon CP, Stone PH, et al. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol 1995; 26:1643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/40\">",
"      Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial. Circulation 1993; 87:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/41\">",
"      Gibson RS, Hansen JF, Messerli F, et al. Long-term effects of diltiazem and verapamil on mortality and cardiac events in non-Q-wave acute myocardial infarction without pulmonary congestion: post hoc subset analysis of the multicenter diltiazem postinfarction trial and the second danish verapamil infarction trial studies. Am J Cardiol 2000; 86:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/42\">",
"      Silber S, Albertsson P, Avil&eacute;s FF, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005; 26:804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/43\">",
"      Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 2004; 110:e340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/44\">",
"      Bugiardini R, Manfrini O, De Ferrari GM. Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography. Arch Intern Med 2006; 166:1391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/45\">",
"      Diver DJ, Bier JD, Ferreira PE, et al. Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial). Am J Cardiol 1994; 74:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37193/abstract/46\">",
"      Roe MT, Harrington RA, Prosper DM, et al. Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators. Circulation 2000; 102:1101.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 68 Version 16.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-9DBBEBA25B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_20_37193=[""].join("\n");
var outline_f36_20_37193=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL PRINCIPLES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Definitions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Elderly patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Cocaine associated myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      INITIAL MEDICAL THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Anti-ischemic and analgesic therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Oxygen",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Nitroglycerin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Morphine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Beta blockers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12643985\">",
"      - Statin therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Antithrombotic therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Antiplatelet therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Anticoagulation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Importance of dosing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Potassium and magnesium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Non-steroidal antiinflammatory drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1151892438\">",
"      Intravenous glucose-insulin-potassium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      ARRHYTHMIA MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      EARLY RISK STRATIFICATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      TIMI risk score",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      EARLY REPERFUSION AND REVASCULARIZATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Avoidance of fibrinolysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Immediate angiography and revascularization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - MI with normal coronary arteries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/68\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/68|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?18/37/19026\" title=\"algorithm 1\">",
"      Algorithm for evaluation and management of possible ACS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/68|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?30/55/31614\" title=\"figure 1\">",
"      TIMI risk score for non-ST elevation ACS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/68|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?33/25/34206\" title=\"table 1\">",
"      Rapid overview ACS",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?5/34/5665?source=related_link\" title=\"calculator 1\">",
"      Calculator: Thrombolysis in Myocardial Infarction (TIMI) score for unstable angina or non ST elevation myocardial infarction",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/2/5162?source=related_link\">",
"      Anticoagulant therapy in non-ST elevation acute coronary syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/20/39242?source=related_link\">",
"      Antiplatelet agents in acute non-ST elevation acute coronary syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/45/36570?source=related_link\">",
"      Assessment of kidney function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/53/11098?source=related_link\">",
"      Beta blockers in the management of acute coronary syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/42/5802?source=related_link\">",
"      Cardiac syndrome X: Angina pectoris with normal coronary arteries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/55/33656?source=related_link\">",
"      Cholesterol lowering after an acute coronary syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/53/28505?source=related_link\">",
"      Classification of unstable angina and non-ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/10/30890?source=related_link\">",
"      Clinical features and treatment of ventricular arrhythmias during acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/16/26889?source=related_link\">",
"      Clinical manifestations and diagnosis of myocarditis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/1/29722?source=related_link\">",
"      Coronary arteriography and revascularization for unstable angina or non-ST elevation acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/39/25209?source=related_link\">",
"      Criteria for the diagnosis of acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/39/39545?source=related_link\">",
"      Evaluation and management of the cardiovascular complications of cocaine abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/57/22421?source=related_link\">",
"      Fibrinolytic (thrombolytic) agents in unstable angina and acute non-ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/43/15034?source=related_link\">",
"      Initial evaluation and management of suspected acute coronary syndrome in the emergency department",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/59/3002?source=related_link\">",
"      Intensity of lipid lowering therapy in secondary prevention of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/31/31222?source=related_link\">",
"      Measurement of serum lipids and lipoproteins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/19/39225?source=related_link\">",
"      Mechanical complications of acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/63/24566?source=related_link\">",
"      Nitrates in the management of acute coronary syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/4/24648?source=related_link\">",
"      Nonselective NSAIDs: Adverse cardiovascular effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/41/44697?source=related_link\">",
"      Overview of the acute management of ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/33/44569?source=related_link\">",
"      Overview of the non-acute management of unstable angina and non-ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/37/35418?source=related_link\">",
"      Prognosis and treatment of cardiogenic shock complicating acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/57/922?source=related_link\">",
"      Right ventricular myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/43/2746?source=related_link\">",
"      Risk stratification after unstable angina or non-ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/52/35658?source=related_link\">",
"      Risk stratification for cardiac events after acute ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/15/8442?source=related_link\">",
"      Sexual activity in patients with heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/14/16615?source=related_link\">",
"      Supraventricular arrhythmias after myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/36/29257?source=related_link\">",
"      Trials of conservative versus early invasive therapy in unstable angina and non-ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/39/3706?source=related_link\">",
"      Variant angina",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_20_37194="Sudden infant death syndrome: Risk factors and risk reduction strategies";
var content_f36_20_37194=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"7\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Sudden infant death syndrome: Risk factors and risk reduction strategies",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/20/37194/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/20/37194/contributors\">",
"     Michael J Corwin, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/20/37194/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/20/37194/contributors\">",
"     George B Mallory, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/20/37194/contributors\">",
"     Teresa K Duryea, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/20/37194/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/20/37194/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/20/37194/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 24, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H6270397\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sudden infant death syndrome (SIDS), also called crib or cot death, is the leading cause of infant mortality between one month and one year of age in the United States. Since the 1990s, however, new studies in pathology and epidemiology have provided the basis for an important evolution in the understanding of SIDS.",
"   </p>",
"   <p>",
"    The risk factors for and measures to reduce the risk of SIDS are discussed in this topic review. Clinical management for the family of an infant who has succumbed to SIDS and alternate diagnostic considerations are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/0/36872?source=see_link\">",
"     \"Sudden unexpected infant death including SIDS: Initial management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6270404\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sudden infant death syndrome (SIDS) is defined as the sudden death of an infant younger than one year of age, which remains unexplained after a thorough case investigation, including performance of a complete autopsy, examination of the death scene, and review of the clinical history [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    This definition emphasizes the necessity of autopsy, death scene investigation, and review of the clinical history when making the diagnosis of SIDS, to exclude other explanations for the sudden unexpected infant death that can mimic SIDS (",
"    <a class=\"graphic graphic_table graphicRef79550 \" href=\"mobipreview.htm?3/47/3837\">",
"     table 1",
"    </a>",
"    ). The evaluation of an infant who has died of suspected SIDS and alternate diagnostic considerations are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/0/36872?source=see_link\">",
"     \"Sudden unexpected infant death including SIDS: Initial management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Due in part to potential inconsistencies in the diagnosis of SIDS, the term \"sudden unexpected infant death\" (SUID) is often used to describe all unexpected infant deaths. The SUID designation can then be sub-divided into explained SUID and unexplained SUID. Unexplained SUID generally includes those cases considered SIDS by the medical examiner, as well as some cases that are not considered SIDS but lack a clear explanation due to uncertain circumstances. Some reports in the literature use the term \"unexplained SUID\" instead of \"SIDS\" to avoid inconsistencies between medical examiners in reporting SIDS as a cause of death.",
"   </p>",
"   <p>",
"    SIDS has similar risk factors to other sleep-related infant deaths, including those attributed to suffocation, asphyxia, and entrapment. Therefore, these are now addressed together in recommendations for a safe infant sleeping environment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/3\">",
"     3",
"    </a>",
"    ]. This topic review will use the term &ldquo;SIDS,&rdquo; but much of the discussion about risk factors and preventative measures applies to other sleep-related infant deaths.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sudden infant death syndrome (SIDS) is the leading cause of infant mortality between one month and one year of age in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/4\">",
"     4",
"    </a>",
"    ]. The risk of SIDS in the United States is &lt;1 per 1000 live births [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. Higher rates (two to three times the national average) are found in black and American",
"    <span class=\"nowrap\">",
"     Indian/Alaskan",
"    </span>",
"    native children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. A disproportionately high rate (15 to 20 percent) of SIDS cases occurs in child care settings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/3,10,11\">",
"     3,10,11",
"    </a>",
"    ]. The risk of SIDS is slightly increased in boys (multivariate OR 1.49 [95% CI 1.14-1.83] in one large European case-control study) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The incidence of SIDS has declined dramatically in countries that have adopted policies encouraging non-prone sleeping (&ldquo;Back to Sleep&rdquo; campaigns). The initial campaigns were in Europe, Australia, and New Zealand [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/13\">",
"     13",
"    </a>",
"    ]. In the United States, the incidence of SIDS has declined by more than 50 percent since the mid-1980s, and the greatest reduction occurred after 1992, when the American Academy of Pediatrics (AAP) issued a recommendation to reduce the risk of SIDS by placing infants in a supine position for sleep [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/3,13-15\">",
"     3,13-15",
"    </a>",
"    ]. Between 1992 and 2001, the SIDS rate in the United States fell from 1.2 to 0.56 per 1000 live births, while the proportion of infants sleeping in the supine position increased from 13 to 72 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. The rate of SIDS then remained constant between 2001 and 2006 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/9\">",
"     9",
"    </a>",
"    ]. Similar declines have occurred in other countries after campaigns to encourage non-prone sleeping [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/18,19\">",
"     18,19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Data from the National Institute of Child Health and Human Development (NICHD) collaborative SIDS Study have helped to define the epidemiologic features of SIDS (",
"    <a class=\"graphic graphic_table graphicRef75379 \" href=\"mobipreview.htm?27/60/28620\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/20\">",
"     20",
"    </a>",
"    ]. This landmark study was a multicenter, population-based, case-controlled project that included 10 percent of the live births in the United States; the study was published in 1988, prior to the widespread use of supine sleep positioning. The pathologic diagnoses were confirmed by an independent panel of forensic pathologists.",
"   </p>",
"   <p>",
"    In the NICHD study, the median age for SIDS deaths was 11 weeks, the peak incidence was between 2 and 4 months, and 90 percent occurred before 6 months of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/20\">",
"     20",
"    </a>",
"    ]. A few sudden unexpected deaths resembling SIDS have been described within the first 24 hours of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/21\">",
"     21",
"    </a>",
"    ]. This unique distribution strongly suggests that critical stages of development or maturation affect the risk of SIDS. The most important conclusion from this study was that no strong predictive",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    diagnostic characteristics of mothers or infants can be identified in most SIDS victims that would permit clinically useful screening for high-risk infants. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Numerous risk factors for sudden infant death syndrome (SIDS) have been identified in observational and case control studies. Those that are consistently identified as independent risk factors include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Maternal factors:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Young maternal age",
"     </li>",
"     <li>",
"      Maternal smoking during pregnancy",
"     </li>",
"     <li>",
"      Late or no prenatal care",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infant and environmental factors:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Preterm birth",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      low birth weight",
"     </li>",
"     <li>",
"      Prone sleeping position",
"     </li>",
"     <li>",
"      Sleeping on a soft surface",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      with bedding accessories such as loose blankets and pillows",
"     </li>",
"     <li>",
"      Bed-sharing (eg, sleeping in parents&rsquo; bed)",
"     </li>",
"     <li>",
"      Overheating",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    More than 95 percent of SIDS cases are associated with one or more risk factors, and in many cases, the risk factors are modifiable (usually sleeping position, sleep environment, or parental smoking) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/22\">",
"     22",
"    </a>",
"    ]. Risk factors for SIDS are discussed below. Those that can be modified to decrease the risk of SIDS are also discussed in the section on prevention. (See",
"    <a class=\"local\" href=\"#H29\">",
"     'Prevention'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Maternal risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two major maternal risk factors for SIDS that are independent of birth weight [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/12,20\">",
"     12,20",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Maternal smoking",
"     </li>",
"     <li>",
"      Age of the mother under 20 years",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These factors increased the risk of SIDS two to fourfold in the NICHD Collaborative SIDS Study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Maternal smoking is an important modifiable risk factor for SIDS, and SIDS rates increase with the amount smoked [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. The strongest effect is from smoking during pregnancy, but exposure of an infant to secondhand smoke is an additional independent risk factor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. Smoking",
"    <span class=\"nowrap\">",
"     prevention/intervention",
"    </span>",
"    programs have the potential to substantially lower SIDS rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/23,27\">",
"     23,27",
"    </a>",
"    ]. Several studies have shown abnormal cardiovascular responses to stimuli (eg, head-up tilt, hypoxemia, or CO2 exposure) and impaired arousal to stimuli in infants born to mothers who smoked during pregnancy, suggesting a possible mechanism for this association [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/28-32\">",
"     28-32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/4/5194?source=see_link&amp;anchor=H9#H9\">",
"     \"Secondhand smoke exposure: Effects in children\", section on 'Sudden infant death syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Maternal drug abuse and all its associated phenomena are also associated with an excessive number of SIDS deaths [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. In one report, a fivefold increase in SIDS risk was reported for infants of substance-abusing mothers in the Los Angeles area [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/35\">",
"     35",
"    </a>",
"    ]. It is not known if this association is related primarily to the biologic effect of drugs in utero, an increased risk of prematurity and low birth weight,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    other postnatal conditions (socioeconomic, environmental, or parenting behavior).",
"   </p>",
"   <p>",
"    Maternal alcohol use is an important risk factor for SIDS in some populations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/36\">",
"     36",
"    </a>",
"    ]. In a population-based case-control study among Northern Plains American Indians, SIDS was significantly associated with periconceptional maternal alcohol use (adjusted odds ratio 6.2, 95% CI 1.6-23.3) and first trimester binge drinking (adjusted OR 8.2, 95% CI 1.9-35.3) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pregnancy complications associated with an increased risk of SIDS include placenta previa, abruptio placenta, premature rupture of membranes, and elevated maternal alpha-fetoprotein [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/7,38-40\">",
"     7,38-40",
"    </a>",
"    ]. The increased risk associated with these complications appears to be independent of their relationship with preterm birth.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6286769\">",
"    <span class=\"h2\">",
"     Infant risk factors",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Prematurity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preterm infants are at a higher risk for SIDS than term infants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/41-44\">",
"     41-44",
"    </a>",
"    ]. Among low and very low birth weight infants, the SIDS rate has consistently been three- to fourfold higher than in term infants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/44\">",
"     44",
"    </a>",
"    ]. The postmenstrual age of peak vulnerability for SIDS appears to occur four to six weeks earlier among preterm than term infants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/41\">",
"     41",
"    </a>",
"    ]. It is unclear whether the population of low birth weight infants is experiencing a decline in the rate of SIDS similar to that in the general population. A decline in SIDS rates among preterm infants was noted in New Zealand [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/43\">",
"     43",
"    </a>",
"    ] but not in Sweden [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/45\">",
"     45",
"    </a>",
"    ]. Preterm infants are subject to the same risk factors for SIDS as term infants, as discussed in greater detail below [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/43,46,47\">",
"     43,46,47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Supine positioning for sleep substantially reduces the risk for SIDS among premature infants. Although there are some concerns that supine positioning may reduce oxygenation in premature infants, two small studies have suggested that this may not be the case, at least among infants who are older than 32 weeks postmenstrual age and not in the acute phase of a respiratory illness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. Therefore, the AAP recommends preterm infants be placed supine for sleep as soon as possible, generally by 32 weeks postmenstrual age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/9,50\">",
"     9,50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The importance of supine sleep position for premature infants was demonstrated in a population based case-control study in England, in which the parents of 325 SIDS cases and 1300 age-matched control infants were interviewed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/46\">",
"     46",
"    </a>",
"    ]. In multivariate analysis, infants who were small at birth (&lt;37 weeks",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    &lt;2500 g) were five times more likely to die of SIDS than infants who were born at term or &gt;2500 g. However, when infants who were small at birth were placed to sleep on their side or prone, they were 15 and 24 times more likely, respectively, to die of SIDS than infants who were not small at birth who were placed on their backs to sleep.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Low birthweight",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants born small for gestational age (SGA) have an increased risk for SIDS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/7,46,51\">",
"     7,46,51",
"    </a>",
"    ]. Low birthweight has a weak but significant association with SIDS risk even after adjustment for gestational age and several other factors known to be associated with low birthweight, including maternal tobacco use and hypertension.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6286913\">",
"    <span class=\"h3\">",
"     Sibling of SIDS victim",
"    </span>",
"    &nbsp;&mdash;&nbsp;Siblings of SIDS victims have a five- to sixfold increase in risk for SIDS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/52-55\">",
"     52-55",
"    </a>",
"    ]. However, assuming a SIDS rate of 0.56 per 1000 live births (0.06 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/16,17\">",
"     16,17",
"    </a>",
"    ], the risk in subsequent siblings for most families remains less than 1 percent.",
"   </p>",
"   <p>",
"    The small but increased risk of SIDS in siblings of SIDS victims is probably due to a combination of biologic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    epidemiologic factors. However, it has not been possible to identify the relative importance of these factors because many of the risk factors for SIDS are the same as those for other causes of infant mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/52\">",
"     52",
"    </a>",
"    ]. In some cases, for example, deaths from inborn errors of metabolism may have been mistaken for SIDS. In other cases, the deaths may have resulted from child abuse or were in some way related to severe deprivation and poverty [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/56\">",
"     56",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/0/36872?source=see_link&amp;anchor=H13236291#H13236291\">",
"     \"Sudden unexpected infant death including SIDS: Initial management\", section on 'Differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6286944\">",
"    <span class=\"h3\">",
"     Twins",
"    </span>",
"    &nbsp;&mdash;&nbsp;In cohort studies, linking data from birth and death records, the crude risk of SIDS among twins is approximately twice that of singletons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/5,6,57\">",
"     5,6,57",
"    </a>",
"    ]. The increased risk is in part attributable to the higher proportion of twins that are preterm",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    of low birth weight [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. However, in subset analyses of some studies, the risk of SIDS among twins born at &ge;37 weeks gestation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/57\">",
"     57",
"    </a>",
"    ] or with birth weight &ge;3000 g [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/6\">",
"     6",
"    </a>",
"    ] remained increased compared with singletons as described below:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      37 to 38 weeks: Relative risk (RR) 1.31",
"     </li>",
"     <li>",
"      39 to 40 weeks: RR 1.47",
"     </li>",
"     <li>",
"      &ge;41 weeks: RR 2.09",
"     </li>",
"     <li>",
"      Birthweight &ge;3000 g: RR 2.98",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6178967\">",
"    <span class=\"h3\">",
"     History of apnea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Apnea or otherwise impaired respiratory function likely falls within the final common pathway of many of the proposed mechanisms for SIDS. However, a history of apnea, apparent life-threatening event (ALTE), or other abnormalities in breathing patterns are not clinically useful predictors of SIDS risk, and monitoring for apnea using standard cardiorespiratory monitors does not reduce SIDS risk. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/58/21414?source=see_link\">",
"     \"Use of home cardiorespiratory monitors in infants\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/34/31272?source=see_link&amp;anchor=H3#H3\">",
"     \"Apparent life-threatening event in infants\", section on 'Lack of causal relationship between ALTE and SIDS'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This was illustrated by the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In case-control studies, a history of apnea or cyanosis is not specifically increased in SIDS victims [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/20\">",
"       20",
"      </a>",
"      ]. Approximately 5 percent of parents of SIDS victims recall cyanotic episodes during the months before death, but this not substantially different from parent recall of cyanotic episodes in control infants and may be influenced by recall bias.",
"     </li>",
"     <li>",
"      Prospective studies have failed to identify respiratory abnormalities that correlate with known SIDS risk factors: in a large series of infants followed longitudinally with cardiorespiratory monitors, neither \"conventional\" (apnea 20 to 30 seconds) nor \"extreme\" events (apnea &gt;30 seconds) correlated with the primary epidemiologic risk factors for SIDS, including time of night of the apnea and the infant's age [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/58\">",
"       58",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/13/43223?source=see_link\">",
"       \"Management of apnea of prematurity\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Sleep position",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prone sleeping position is the strongest modifiable risk factor for SIDS. In case-control studies, odds ratios for the risk of prone sleeping or non-supine sleeping range between 2.3 and 13.1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/9,12,59-64\">",
"     9,12,59-64",
"    </a>",
"    ]. Additional support for this association comes from the decreased rate of SIDS in various countries following recommendations to place infants on their back or side to sleep [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/14,16,17,65-67\">",
"     14,16,17,65-67",
"    </a>",
"    ]. Supine positioning also is beneficial for infants born prematurely, as discussed above. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Prematurity'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Avoidance of side positioning is also important, perhaps because the probability of rolling from the side to the prone position is greater than that of rolling from the supine to the prone position (see",
"    <a class=\"local\" href=\"#H2\">",
"     'Epidemiology'",
"    </a>",
"    above) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/68-71\">",
"     68-71",
"    </a>",
"    ]. As the proportion of infants placed to sleep in the prone position has decreased, the relative contribution of side-sleeping to SIDS risk has increased [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/46,68,72-75\">",
"     46,68,72-75",
"    </a>",
"    ], as suggested by the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a population-based case-control study, the risk of SIDS was increased for infants placed on the side and found in the prone position (adjusted odds ratio 8.7) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/73\">",
"       73",
"      </a>",
"      ]. In the same study, the risk of SIDS was also increased among infants who were usually placed supine but were placed on their sides or prone for the last sleep (OR 6.9 and 8.2, respectively).",
"     </li>",
"     <li>",
"      Other case-control studies have demonstrated an increased risk of SIDS when infants unaccustomed to the prone position are placed in the prone position [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/76,77\">",
"       76,77",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A population-based study noted decreases in SIDS mortality associated with non-prone sleep positioning and documented further decreases associated with specifically supine positioning of infants for sleep [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/78\">",
"       78",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Use of infant &ldquo;sleep positioners&rdquo; to position infants on their side has also been associated with several cases of infant deaths, as reported in a",
"      <a class=\"external\" href=\"file://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm227733.htm\">",
"       safety alert",
"      </a>",
"      by the United States Food and Drug Administration (FDA) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/79\">",
"       79",
"      </a>",
"      ]. Between 1997 and 2011, the deaths of 13 infants in the United States were linked to use of infant sleep positioners [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/80\">",
"       80",
"      </a>",
"      ]. Most of the infants had been placed on their side in the positioner to sleep, and were found prone or with the positioner against their face. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The increased risk among infants unaccustomed to the side or prone position highlights the importance of supine positioning for every sleep [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Sleep environment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Various aspects of the sleep environment, including the sleep surface, sleepwear, bedding, room temperature, and whether or not the bed or room are shared with parents also appear to affect the risk of SIDS, as illustrated below.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Soft sleeping surface",
"      </strong>",
"      &ndash; Use of a soft sleeping surface is a consistent risk factor for SIDS in several case-control studies, especially in association with prone positioning [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/81\">",
"       81",
"      </a>",
"      ]. In one study, soft bedding increased the risk of SIDS fivefold, and the combination of prone positioning and soft bedding increased the risk 21-fold (95% CI 7.8-56.2) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/82\">",
"       82",
"      </a>",
"      ]. Other forms of soft bedding (eg, polystyrene beads, natural fiber mattresses) also have been associated with an increased risk of SIDS [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/83,84\">",
"       83,84",
"      </a>",
"      ]. Sheepskin bedding has been associated with an increased risk for SIDS when infants are placed in the prone position [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/85,86\">",
"       85,86",
"      </a>",
"      ]. Sleep surfaces marketed commercially with claims that they reduce SIDS risk have not been adequately tested for either safety or benefit [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Loose bedding",
"      </strong>",
"      &ndash; Loose bedding accessories such as blankets, quilts, and pillows also increase the risk of SIDS by as much as fivefold, independent of sleeping position [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/87,88\">",
"       87,88",
"      </a>",
"      ]. The association appears to be mediated by the loose bedding covering the head or otherwise obstructing airflow [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/89,90\">",
"       89,90",
"      </a>",
"      ]. There are reports of deaths by \"suffocation\" attributed to crib bumper pads [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/91\">",
"       91",
"      </a>",
"      ], prompting the Canadian Pediatric Society to caution against their use [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/92\">",
"       92",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Bed-sharing",
"      </strong>",
"      &ndash; A variety of studies report an association between SIDS risk and infants sharing a bed with their parents [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/71,93-98\">",
"       71,93-98",
"      </a>",
"      ]. In a meta-analysis, the combined odds ratio (OR) for bed-sharing versus non bed-sharing infants was 2.89 (95% CI 1.99-4.18) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/95\">",
"       95",
"      </a>",
"      ]. The risk of bed sharing is greatest for infants younger than three months of age (OR, 10.37; 95% CI 4.44-24.21) or for infants of mothers who smoke (OR, 6.27; 95% CI 3.94-9.99). In addition, there is a consistent association between increased risk of SIDS and sharing a couch or sofa with parents during sleep [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/18,82,93,94,99\">",
"       18,82,93,94,99",
"      </a>",
"      ]. Other factors that increase the risk of bed-sharing include soft sleeping surfaces, additional bedding such as pillows and blankets, the presence of multiple bed-sharers, and consumption of alcohol by the bed-sharing adult [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/9\">",
"       9",
"      </a>",
"      ]. &nbsp;",
"      <br/>",
"      <br/>",
"      The issue of bed-sharing has been controversial, in part because the risk of bed-sharing may be relatively low if none of these additional risk factors are present, and because of potential beneficial effects of bed-sharing on breastfeeding [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/100-103\">",
"       100-103",
"      </a>",
"      ]. However, some of the factors that contribute to the risk of bed-sharing cannot be predicted or controlled, and breastfeeding can still be supported by room-sharing. Therefore, we agree with the AAP recommendation against bed-sharing, although room-sharing is encouraged [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/3\">",
"       3",
"      </a>",
"      ]. There is no evidence to suggest that in-bed &ldquo;co-sleeper&rdquo; devices reduce the risk of bed-sharing. Guidelines in the US and Australia suggest that twins and higher-order multiples also not sleep in the same crib, although this is currently a common practice [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/9,104,105\">",
"       9,104,105",
"      </a>",
"      ]. This suggestion is based on a lack of evidence for either the safety or benefits of bed-sharing by twins, and because these infants are likely to have other risk factors for SIDS, such as low birthweight",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      prematurity. &nbsp;",
"     </li>",
"     <li>",
"      <strong>",
"       Car seats and other sitting devices &ndash;",
"      </strong>",
"      Use of a car seat or other sitting device (stroller, swing, or infant carrier) for sleep has been associated with some sleep-related infant deaths [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/9\">",
"       9",
"      </a>",
"      ]. This is because the sitting position tends to potentiate gastroesophageal reflux and may reduce oxygenation in young infants [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/106,107\">",
"       106,107",
"      </a>",
"      ]. In addition, some cases have been reported in which an infant suffered suffocation after a car seat accidentally overturned when placed on a soft bed or couch [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/108\">",
"       108",
"      </a>",
"      ]. Other deaths have been associated with the use of sling carriers for young infants [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/109\">",
"       109",
"      </a>",
"      ]. Use of a car seat for car travel has safety benefits that clearly outweigh the small risk of SIDS associated with sleep in these devices. Therefore, the AAP recommends against",
"      <strong>",
"       routine",
"      </strong>",
"      use of car seats for sleep outside of a car but continues to strongly recommend their use for car travel [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/110\">",
"       110",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Overheating",
"      </strong>",
"      &ndash; The risk of SIDS increases with the amount of clothing or blankets on an infant and with room temperature, but it is not clear whether these risks are mediated by head-covering and rebreathing or by overheating [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/9\">",
"       9",
"      </a>",
"      ]. In a population-based case-control study among Northern Plains American Indians, SIDS was significantly associated with two or more layers of clothing on the infant (adjusted OR 6.2, 95% CI 1.4-26.5) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/37\">",
"       37",
"      </a>",
"      ]. Another study noted an increased risk with swaddling or in heated rooms [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/84\">",
"       84",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Swaddling",
"      </strong>",
"      &ndash; Whether swaddling of infants increases or decreases the risk for SIDS is unclear, and may depend on sleeping position. Swaddling increases the risk for SIDS associated with prone sleeping position [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/84\">",
"       84",
"      </a>",
"      ]. By contrast, limited evidence suggests that swaddling in the supine position does not increase SIDS risk and might actually be protective [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/87\">",
"       87",
"      </a>",
"      ]. This may be because swaddling keeps the infant in the unsafe or safe sleeping position, respectively. Swaddled infants are less likely to be aroused by external stimuli, but this effect is not seen in infants who are routinely swaddled, and it is unclear if this is clinically relevant in infants who are in the supine position [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/111,112\">",
"       111,112",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13238420\">",
"    <span class=\"h2\">",
"     Protective factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following factors are somewhat protective against SIDS. However, these effects are generally weak and are outweighed by the modifiable risk factors described above.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Room-sharing",
"      </strong>",
"      &ndash; Room-sharing, without bed-sharing, between parents and infants appears to reduce the risk of SIDS [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/12,82,93,94,99\">",
"       12,82,93,94,99",
"      </a>",
"      ]. In a case-control study from New Zealand in which 393 infants who died from SIDS were compared with 1592 controls, the relative risk associated with sleeping in the prone position was reduced by approximately 80 percent if the infant slept in the same room as an adult [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/113\">",
"       113",
"      </a>",
"      ]. A similar reduction in the risk of SIDS was not seen if the infant shared a room with another child. Having the infant sleep in close proximity to the mother (but on separate surfaces) also supports breast-feeding.",
"     </li>",
"     <li>",
"      <strong>",
"       Pacifier use",
"      </strong>",
"      &ndash; Use of a pacifier (\"dummy,\" \"soother\") during sleep appears to reduce the risk of SIDS. This was shown in a meta-analysis of seven studies, in which the multivariate summary odds ratio was 0.71 [95% CI 0.59-0.85] for usual pacifier use and 0.39 [95% CI 0.31-0.50] for pacifier use during last sleep [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/114\">",
"       114",
"      </a>",
"      ]. The mechanism for this association is unclear; it may be related to the lowered arousal threshold during pacifier use [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/115,116\">",
"       115,116",
"      </a>",
"      ] (see",
"      <a class=\"local\" href=\"#H15\">",
"       'Pathogenesis'",
"      </a>",
"      below). Because of this apparent reduction in risk, the AAP suggests offering a pacifier during sleep, provided that it does not interfere with establishment of breast feeding [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Breastfeeding",
"      </strong>",
"      &ndash; The association between breastfeeding and risk of SIDS is inconsistent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/74,82,117-121\">",
"       74,82,117-121",
"      </a>",
"      ], and analysis in some studies is complicated by confounding factors (eg, maternal age, smoking) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/122-126\">",
"       122-126",
"      </a>",
"      ]. However, a meta-analysis that controlled for potentially protective factors, such as smoke exposure and sociodemographic factors, concluded that breastfeeding has an independent protective effect against SIDS (multivariable summary odds ratio for any breastfeeding was 0.55 [95% CI 0.44-0.69]) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/127\">",
"       127",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Fan use",
"      </strong>",
"      &ndash; In a population-based case-control study performed in California, use of a fan was associated with a 72 percent reduction in SIDS risk (adjusted odds ratio 0.28, 95% CI 0.10-0.77) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/128\">",
"       128",
"      </a>",
"      ]. The effect was greater for infants with other environmental SIDS risk factors, including prone or side sleeping, bed sharing, and warmer room temperature. The study was limited by low participation rates and recall bias, and needs confirmation by prospective studies.",
"     </li>",
"     <li>",
"      <strong>",
"       Immunizations",
"      </strong>",
"      &ndash; SIDS is not associated with diphtheria-tetanus-pertussis (DTP) vaccine or other vaccines [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/129-131\">",
"       129-131",
"      </a>",
"      ]. In fact, immunization may lower the risk of SIDS [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/132-135\">",
"       132-135",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A triple-risk model for sudden infant death syndrome (SIDS) has been proposed, suggesting that SIDS occurs in infants with underlying vulnerability (eg, genetic pattern, brainstem abnormality) who experience a trigger event (eg, airflow obstruction, maternal smoking or infection), at a vulnerable developmental stage of the central nervous or immune system [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/71,136-138\">",
"     71,136-138",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Underlying vulnerability",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Brain abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Emerging evidence suggests a brainstem abnormality or maturational delay related to neuroregulation or cardiorespiratory control is a critical contributor to the pathogenesis of SIDS. This hypothesis is suggested by the following findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Maternal and antenatal risk factors indicating a less than optimal intrauterine environment have been described for infants who later died of SIDS [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/20,139,140\">",
"       20,139,140",
"      </a>",
"      ]. These observations suggest that the presumed brain disorder may originate before birth (see",
"      <a class=\"local\" href=\"#H4\">",
"       'Maternal risk factors'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Subtle abnormalities in the regulation of cardiac, respiratory, and sleep arousal patterns have been observed in infants who subsequently succumbed to SIDS [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/141,142\">",
"       141,142",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Abnormalities in serotonin (5HT) signaling in the brain have been implicated as a mechanism. Several studies of infants who succumbed to SIDS have demonstrated subtle alterations or \"delayed maturation\" in the arcuate nucleus and other regions of the brain that participate in ventilatory and blood pressure responses to hypoxia and hypercarbia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/143-146\">",
"     143-146",
"    </a>",
"    ]. Furthermore, specific abnormalities of serotonin signaling have been shown, including decreased 5-HT(1A) receptor binding in the medullary areas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/147-149\">",
"     147-149",
"    </a>",
"    ]. Male infants had particularly low binding, consistent with the clinical observation of a male predominance in SIDS cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/148\">",
"     148",
"    </a>",
"    ]. Affected infants appear to have a deficiency in serotonin and its key biosynthetic enzyme, tryptophan hydroxylase, in the medulla [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/149\">",
"     149",
"    </a>",
"    ]. Because serotonin signaling in the medulla is known to influence a broad range of autonomic processes, these findings are consistent with the hypothesis that SIDS is related to serotonin-mediated dysregulation of the autonomic nervous system. Furthermore, serotonin signaling is altered by exposure to nicotine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/147,150\">",
"     147,150",
"    </a>",
"    ], providing a potential explanation for the association between maternal smoking and SIDS risk.",
"   </p>",
"   <p>",
"    In one of the studies cited above [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/149\">",
"     149",
"    </a>",
"    ], 95 percent of the infants dying of SIDS had one or more additional risk factors for SIDS (eg, prone position, intercurrent illness before death, male sex, or prematurity), and 88 percent had two or more risk factors. These observations underscore the notion that SIDS results from the simultaneous occurrence of multiple events.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Genetic factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role that genetic factors play in susceptibility to SIDS is not clear. On the one hand, the overall low rate of SIDS in siblings, the lack of concordance in twins, and the finding that like-sex twins are at no greater risk than unlike-sex twins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/5,6\">",
"     5,6",
"    </a>",
"    ] suggest that SIDS is not a genetic disorder. On the other hand, the identification of gene polymorphisms in SIDS victims suggests that specific genetic polymorphisms may interact with specific environmental risk factors to increase the susceptibility to SIDS in critical situations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/151,152\">",
"     151,152",
"    </a>",
"    ]. Specific genetic polymorphisms in the following genes have been proposed to play a role in SIDS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/151,152\">",
"     151,152",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Genes encoding cardiac ion channels [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/153-158\">",
"       153-158",
"      </a>",
"      ] or proteins involved in myocardial conduction [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/159\">",
"       159",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Serotonin transporter gene [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/160-164\">",
"       160-164",
"      </a>",
"      ], or monoamine oxidase A (MAOA) gene, which affects serotonergic and noradrenergic transmission [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/165\">",
"       165",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Genes involved in the development of the autonomic nervous system [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/166,167\">",
"       166,167",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Partial deletions of complement component C4 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/168\">",
"       168",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Interleukin-10 promoter gene [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/169-171\">",
"       169-171",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Testis-specific Y like gene [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/172\">",
"       172",
"      </a>",
"      ], which is expressed in the fetal brain [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/173\">",
"       173",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Genes encoding heat shock proteins [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/162\">",
"       162",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Environmental triggers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Little is known about the mechanism of death in SIDS. One report described heart rate and respiratory effort wave form data recorded by memory monitors in three children who died while being monitored and whose autopsies reported SIDS as the cause of death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/174\">",
"     174",
"    </a>",
"    ]. Bradycardia, not apnea, was the predominant feature in these infants' deaths. One major caveat to interpreting this report is that the home monitors could not have detected obstructive apnea and did not record oxyhemoglobin saturation data.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Prone position",
"      </strong>",
"      &ndash; The mechanism for the increase in SIDS risk with the prone position is not known. Some studies have suggested that the prone position predisposes to suffocation, precipitated by decreased arousal [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/175-177\">",
"       175-177",
"      </a>",
"      ], the type of bedding, and overheating [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/68,81,83,84,178,179\">",
"       68,81,83,84,178,179",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Decreased arousal in the prone position was suggested by a study of Belgian infants, in which prone sleep position was associated with longer duration of sleep, longer obstructive events, decreased behavioral arousal, longer interval between obstruction and arousal, and overall decreased reaction (arousal or sigh) to obstructive events [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/175\">",
"       175",
"      </a>",
"      ]. In another study, arousal thresholds during both active and quiet sleep, were higher in infants younger than five to six months of age [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/176\">",
"       176",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Accidental suffocation in the prone position was suggested by a study of 25 infant deaths that occurred during sleep in the prone position on cushions filled with polystyrene beads, accidental suffocation by rebreathing was found to be the most likely cause of death in most of the infants [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/83\">",
"       83",
"      </a>",
"      ]. The cushion was thought to allow limited movement of the infant's head to obtain fresh air, and the estimated amount of subsequent rebreathing was lethal in a rabbit model. Similarly, in a study of 393 cases of SIDS in New Zealand, infants who were found in the prone position with their face down were more likely to be younger, have a low birthweight, and to have used sheepskin bedding or pillows as compared to infants with SIDS found in other positions (prone with face to side, supine, or side) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/180\">",
"       180",
"      </a>",
"      ]. This finding suggests that infants dying of SIDS in the face down prone position represent a distinct subgroup, and that the mechanism of SIDS may differ depending on specific circumstances related to the infant's sleeping position.",
"     </li>",
"     <li>",
"      <strong>",
"       Cardiac dysfunction",
"      </strong>",
"      &ndash; Some studies have suggested the control of cardiac function may be abnormal in infants at risk for SIDS, but results have been inconsistent. One large, prospective study found mildly increased heart rates in infants who subsequently died of SIDS [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/181\">",
"       181",
"      </a>",
"      ]. Others have described prolonged QT intervals on electrocardiographic analysis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/182\">",
"       182",
"      </a>",
"      ] or sodium channel mutations associated with long QT syndrome in post-mortem tissues [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/183,184\">",
"       183,184",
"      </a>",
"      ]. However, given the limitations of small sample sizes in cross-sectional studies of rare conditions, the incidence and role of cardiac abnormalities in SIDS remains controversial. Based on a study of the prevalence of functionally significant genetic variants associated with long QT syndrome, such abnormalities appear to be present in fewer than 10 percent of SIDS cases. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/9/2202?source=see_link&amp;anchor=H22#H22\">",
"       \"Clinical features of congenital long QT syndrome\", section on 'Sudden infant death syndrome'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Infection",
"      </strong>",
"      &ndash; Infection is clearly the cause in a sub-group of explained sudden unexpected deaths in infancy, but its role in SIDS remains unclear [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/185\">",
"       185",
"      </a>",
"      ]. Autopsy findings in infants dying from SIDS have some similarities with those of infants dying of toxemic shock, although there may be minimal inflammatory tissue reaction. This raises the possibility that some cases of SIDS may have an infectious trigger, leading to a toxic shock-like event [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/186,187\">",
"       186,187",
"      </a>",
"      ]. Implicated organisms include enteric bacteria (enterotoxigenic S. aureus and E. coli), and mild viral infections [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/186-188\">",
"       186-188",
"      </a>",
"      ]. Variations in the innate immune system, including polymorphisms that result in an exaggerated pro-inflammatory response, have been found in a higher proportion of SIDS cases than in controls [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/169,171,186\">",
"       169,171,186",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Genetic factors'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      Distinguishing between autopsy findings that represent perimortem contamination and those that suggest infection as a trigger for SIDS is challenging and controversial. More than 70 percent of post-mortem bacteriological samples grow organisms when cultured, but this is not sufficient to attribute infection as a cause or trigger for death. However, one well-conducted study found that infants dying of SIDS were more likely to harbor organisms that are potentially pathogenic, as compared with infants dying from clearly non-infectious causes (eg, accidents or congenital heart disease) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/189\">",
"       189",
"      </a>",
"      ]. The bacterial colonization documented in this study could also be explained as an epiphenomenon, caused by another established epidemiological risk factor for SIDS such as prone sleeping, but not directly implicated as a cause of death.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Developmental timing",
"    </span>",
"    &nbsp;&mdash;&nbsp;SIDS usually occurs between the second and fourth months of life, a period of remarkable developmental changes in cardiac, ventilatory, and",
"    <span class=\"nowrap\">",
"     sleep/wake",
"    </span>",
"    patterns in otherwise normal infants. This coincidence of timing suggests that SIDS infants are vulnerable to sudden death during a critical period of autonomic maturation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although a number of epidemiologic and physiologic factors are associated with an increased risk for sudden infant death syndrome (SIDS), as described above, these factors cannot prospectively identify the infant at high risk for SIDS. Therefore, modifiable risk factors should be addressed for all infants, to reduce the risk of SIDS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/190-192\">",
"     190-192",
"    </a>",
"    ]. Attention to these modifiable risks should begin in the newborn nursery because sudden unexpected deaths in association with such risk factors have been reported as early as the first day of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/21\">",
"     21",
"    </a>",
"    ], and appropriate role modeling by nursery staff has been shown to increase maternal adherence to recommendations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/193\">",
"     193",
"    </a>",
"    ]. Resources including training videos for families, child care providers, and medical professionals, are available from the",
"    <a class=\"external\" href=\"file://www.sidscenter.org/whatworks.html\">",
"     National SUID/SIDS resource center website",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/194\">",
"     194",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following recommendations are made by the American Academy of Pediatrics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/3\">",
"     3",
"    </a>",
"    ], the Canadian Paediatric Society [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/192\">",
"     192",
"    </a>",
"    ],",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the United Kingdom Department of Health [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/191,195\">",
"     191,195",
"    </a>",
"    ]. The recommendations apply to infants up to one year of age. The data underlying these recommendations are primarily case-control studies, which were described above. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Risk factors'",
"    </a>",
"    above.) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6286180\">",
"    <span class=\"h2\">",
"     Prenatal measures",
"    </span>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Maternal risk factors'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Smoking and other substances",
"      </strong>",
"      &ndash; Mothers should avoid use of tobacco alcohol illicit drugs during pregnancy as well as after birth.",
"     </li>",
"     <li>",
"      <strong>",
"       Prenatal care",
"      </strong>",
"      &ndash; Pregnant women should receive regular prenatal care.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6286188\">",
"    <span class=\"h2\">",
"     Sleep position and environment",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Supine sleep position",
"      </strong>",
"      &ndash; All infants, including infants with a history of prematurity, should be placed to sleep on their backs (supine) for every sleep, even if they are able to roll from their backs to the prone position [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/191\">",
"       191",
"      </a>",
"      ]. Side sleeping is no longer recommended. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Sleep position'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The recommendation for supine sleeping also applies to infants with gastroesophageal reflux because normal infants effectively protect their airway after an episode of reflux. A rare exception is an infant with impaired swallowing mechanisms due to neurologic dysfunction. The head of the mattress should not be elevated because this is not effective for reducing reflux. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/46/30441?source=see_link&amp;anchor=H24#H24\">",
"       \"Gastroesophageal reflux in infants\", section on 'Positioning therapy'",
"      </a>",
"      .) &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      Sitting devices, including car seats, infant carriers, strollers, and swings, should not be used for routine sleep. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Sleep environment'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"     <li>",
"      Infant &ldquo;sleep positioners&rdquo; (wedges and other positioning devices) should not be used, as described in an",
"      <a class=\"external\" href=\"file://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm227733.htm\">",
"       FDA Safety Alert",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/79\">",
"       79",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Firm sleep surface",
"      </strong>",
"      &ndash; Infants should always be placed to sleep in a crib or bassinet on a firm surface that is certified for use as infant bedding. The following sleep surfaces may be dangerous and should be AVOIDED: (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Sleep environment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Beds designed for older children and adults, including those with bed-rails.",
"     </li>",
"     <li>",
"      Soft sleep surfaces, including polystyrene-filled cushions and sheepskin bedding.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Room-sharing without bed-sharing",
"      </strong>",
"      &ndash; Infants should sleep in the parents' room for the first six months, in a crib (or cradle or bassinet) but NOT in the parents&rsquo; bed. They should not sleep on or share a sofa, recliner, armchair, or other type of cushioned chair. (See",
"      <a class=\"local\" href=\"#H13238420\">",
"       'Protective factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <strong>",
"       Avoid soft objects in the bed",
"      </strong>",
"      &ndash; Soft objects (eg, pillows, stuffed animals) and loose blankets should be kept out of the crib, bassinet, or cradle. Bumper pads should not be used. The infant's head should remain uncovered. If blankets are used, the infant's feet should be placed at the bottom of the crib and the blankets tucked around the mattress to prevent the infant from moving into a position in which the head could be covered by the blanket (",
"      <a class=\"graphic graphic_figure graphicRef52080 \" href=\"mobipreview.htm?28/1/28691\">",
"       figure 1",
"      </a>",
"      ). Infant sleep clothing (&ldquo;sleeper&rdquo; or &ldquo;sleep sac&rdquo;) is a safe alternative to a blanket, provided that the sleep clothing is appropriately sized and selected to avoid overheating. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Sleep environment'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"     <li>",
"      <strong>",
"       Avoid overheating",
"      </strong>",
"      &ndash; Overheating should be avoided; the infant should be lightly clothed for sleep, and the bedroom temperature should be comfortable for a lightly clothed adult. If the infant is dressed in a sleeper, no more than a thin blanket should be necessary. Infants should not sleep next to a radiator or heater, or in direct sunshine. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Sleep environment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <strong>",
"       Pacifier use &ndash;",
"      </strong>",
"      We suggest offering a pacifier at sleep initiation because of some evidence that this protective against SIDS, even if the pacifier subsequently falls out of the infant&rsquo;s mouth. (See",
"      <a class=\"local\" href=\"#H13238420\">",
"       'Protective factors'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      The pacifier should not be attached to a strap or cord because this can present a strangulation risk. It should be used when placing the infant to sleep but not reinserted once the infant is asleep. The AAP suggests delaying the introduction of the pacifier until one month of age for breastfed infants to ensure that breastfeeding is firmly established [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/196\">",
"       196",
"      </a>",
"      ]. There is some concern that pacifier use may increase the risk of acute otitis media (AOM) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/197\">",
"       197",
"      </a>",
"      ]. However, the incidence of AOM is relatively low during the first six months of life when the risk of SIDS is greatest. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/39/42616?source=see_link\">",
"       \"Breastfeeding: Parental education and support\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/60/29642?source=see_link&amp;anchor=H4#H4\">",
"       \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\", section on 'Risk factors'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9951026\">",
"    <span class=\"h2\">",
"     Other measures",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Smoking and other substances",
"      </strong>",
"      &ndash; Mothers should avoid smoking, alcohol, and illicit drug use after birth as well as during pregnancy. Postnatal exposure of infants to tobacco smoke should be avoided; providers should encourage the parents to quit smoking and to set a firm rule against smoking in the house or car. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Maternal risk factors'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/4/5194?source=see_link&amp;anchor=H9#H9\">",
"       \"Secondhand smoke exposure: Effects in children\", section on 'Sudden infant death syndrome'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/58/41895?source=see_link&amp;anchor=H9#H9\">",
"       \"Control of secondhand smoke exposure\", section on 'The home environment'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Breastfeeding",
"      </strong>",
"      &ndash; Breastfeeding is recommended for possible effects on reducing the risk of SIDS, in addition to other benefits. (See",
"      <a class=\"local\" href=\"#H13238420\">",
"       'Protective factors'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/47/32505?source=see_link\">",
"       \"Infant benefits of breastfeeding\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       &ldquo;Tummy time&rdquo;",
"      </strong>",
"      &ndash; Prone positioning is encouraged when the infant is awake and observed to facilitate the development of shoulder girdle strength and avoidance of occipital plagiocephaly [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/100\">",
"       100",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/37/10841?source=see_link\">",
"       \"Overview of craniosynostosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     No benefit from home monitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no evidence to support the role of home cardiorespiratory (CR) monitors in SIDS prevention, and the AAP recommends against prescribing home monitors for this purpose [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/20/37194/abstract/3\">",
"     3",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Hypotheses proposed during the 1970s suggested that infants with a history of apnea or an apparent life-threatening event (ALTE) are at risk for SIDS even if they are otherwise asymptomatic, and that death could be prevented by CR monitoring. However, studies done over the past decade have failed to confirm the relationship between SIDS and apnea. Moreover, studies of infants with a history of ALTE and others considered to be at risk for SIDS (such as siblings of SIDS victims) were unable to show any benefit of CR monitoring in preventing SIDS deaths. These issues are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/34/31272?source=see_link&amp;anchor=H3#H3\">",
"     \"Apparent life-threatening event in infants\", section on 'Lack of causal relationship between ALTE and SIDS'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/58/21414?source=see_link\">",
"     \"Use of home cardiorespiratory monitors in infants\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Counseling parents of asymptomatic infants with risk factors for SIDS who request a home monitor may be challenging.&nbsp;If parents are concerned about SIDS and request a monitor, we suggest that the clinician engage them in a focused conversation about the potential benefits and risks of using a home monitor before making the decision. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/58/21414?source=see_link&amp;anchor=H5#H5\">",
"     \"Use of home cardiorespiratory monitors in infants\", section on 'Asymptomatic infants with risk factors for sudden infant death syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/38/38497?source=see_link\">",
"       \"Patient information: Sudden infant death syndrome (SIDS) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?7/40/7811?source=see_link\">",
"       \"Patient information: Sudden infant death syndrome (SIDS) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sudden infant death syndrome (SIDS) is defined as the sudden death of an infant less than one year of age, which remains unexplained after a thorough case investigation, including performance of a complete autopsy, examination of the death scene, and review of the clinical history. (See",
"      <a class=\"local\" href=\"#H6270404\">",
"       'Definition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      SIDS is the leading cause of infant mortality between one month and one year of age in the United States. The rate of SIDS peaks between two and four months of age, and 90 percent of cases occur before six months of age. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"     <li>",
"      The mechanism of sudden death is unknown. The most compelling hypothesis involves a brainstem abnormality or maturational delay related to neuroregulation or cardiorespiratory control, combined with a trigger event such as airflow obstruction. The mechanism most likely involves abnormalities of serotonin (5-HT) signaling. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A number of risk factors for SIDS have been identified (",
"      <a class=\"graphic graphic_table graphicRef75379 \" href=\"mobipreview.htm?27/60/28620\">",
"       table 2",
"      </a>",
"      ). These include exposure to cigarette smoke, maternal age &lt;20 years, prematurity, prone sleeping position, soft bedding, and overheating. Apnea of prematurity, although a marker for prematurity, is not a risk factor for SIDS. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      To minimize the risk for SIDS, we recommend each of the following measures (see",
"      <a class=\"local\" href=\"#H6286188\">",
"       'Sleep position and environment'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      We recommend that all infants, including those with a history of prematurity who are older than 32 weeks postmenstrual age, be placed to sleep on their backs (supine) for every sleep (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Side sleeping is not recommended. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Sleep position'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that infants should sleep on a firm sleep surface (crib, cradle, or bassinet) without pillows or other soft objects, loose bedding, excessive clothing or sleep positioners (",
"      <a class=\"graphic graphic_figure graphicRef52080 \" href=\"mobipreview.htm?28/1/28691\">",
"       figure 1",
"      </a>",
"      ) (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). We also recommend AGAINST bed-sharing (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ), although room-sharing is encouraged. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Sleep environment'",
"      </a>",
"      above.) &nbsp; &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      Expectant mothers should avoid smoking during pregnancy because of effects on SIDS risk, in addition to other adverse effects of smoking. Exposure of an infant to secondhand smoke after delivery also probably increases SIDS risk. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Maternal risk factors'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9951026\">",
"       'Other measures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Measures that may help protect against SIDS risk include breastfeeding and use of a pacifier when placing the infant to sleep. These effects are weak and are outweighed by the modifiable risk factors described above. (See",
"      <a class=\"local\" href=\"#H13238420\">",
"       'Protective factors'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The use of home monitors has not been proven to reduce the incidence of SIDS and is not recommended for this purpose. (See",
"      <a class=\"local\" href=\"#H31\">",
"       'No benefit from home monitors'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/1\">",
"      Centers for Disease Control and Prevention (CDC). Sudden infant death syndrome--United States, 1983-1994. MMWR Morb Mortal Wkly Rep 1996; 45:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/2\">",
"      Willinger M, James LS, Catz C. Defining the sudden infant death syndrome (SIDS): deliberations of an expert panel convened by the National Institute of Child Health and Human Development. Pediatr Pathol 1991; 11:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/3\">",
"      Task Force on Sudden Infant Death Syndrome. SIDS and Other Sleep-Related Infant Deaths: Expansion of Recommendations for a Safe Infant Sleeping Environment. Pediatrics 2011; 128:1030.",
"     </a>",
"    </li>",
"    <li>",
"     Center for Disease Control and Prevention. Sudden unexpected infant death and sudden infant death syndrome. Available at: file://www.cdc.gov/sids/ (Accessed on February 23, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/5\">",
"      Malloy MH, Freeman DH Jr. Sudden infant death syndrome among twins. Arch Pediatr Adolesc Med 1999; 153:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/6\">",
"      Platt MJ, Pharoah PO. The epidemiology of sudden infant death syndrome. Arch Dis Child 2003; 88:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/7\">",
"      Getahun D, Amre D, Rhoads GG, Demissie K. Maternal and obstetric risk factors for sudden infant death syndrome in the United States. Obstet Gynecol 2004; 103:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/8\">",
"      Mathews TJ, Menacker F, MacDorman MF, Centers for Disease Control and Prevention, National Center for Health Statistics. Infant mortality statistics from the 2002 period: linked birth/infant death data set. Natl Vital Stat Rep 2004; 53:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/9\">",
"      Task Force on Sudden Infant Death Syndrome, Moon RY. SIDS and other sleep-related infant deaths: expansion of recommendations for a safe infant sleeping environment. Pediatrics 2011; 128:e1341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/10\">",
"      Moon RY, Sprague BM, Patel KM. Stable prevalence but changing risk factors for sudden infant death syndrome in child care settings in 2001. Pediatrics 2005; 116:972.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/11\">",
"      Kiechl-Kohlendorfer U, Moon RY. Sudden infant death syndrome (SIDS) and child care centres (CCC). Acta Paediatr 2008; 97:844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/12\">",
"      Carpenter RG, Irgens LM, Blair PS, et al. Sudden unexplained infant death in 20 regions in Europe: case control study. Lancet 2004; 363:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/13\">",
"      Willinger M, Hoffman HJ, Hartford RB. Infant sleep position and risk for sudden infant death syndrome: report of meeting held January 13 and 14, 1994, National Institutes of Health, Bethesda, MD. Pediatrics 1994; 93:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/14\">",
"      American Academy of Pediatrics AAP Task Force on Infant Positioning and SIDS: Positioning and SIDS. Pediatrics 1992; 89:1120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/15\">",
"      Positioning and sudden infant death syndrome (SIDS): update. American Academy of Pediatrics Task Force on Infant Positioning and SIDS. Pediatrics 1996; 98:1216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/16\">",
"      Mathews TJ, Menacker F, MacDorman MF. Infant mortality statistics from the 2001 period linked birth/infant death data set. Natl Vital Stat Rep 2003; 52:1.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. CDC Wonder. Compressed Mortality File. Underlying Cause-of-Death wonder.cdc.gov/mortSQL.html (Accessed on January 05, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/18\">",
"      Blair PS, Sidebotham P, Berry PJ, et al. Major epidemiological changes in sudden infant death syndrome: a 20-year population-based study in the UK. Lancet 2006; 367:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/19\">",
"      Hauck FR, Tanabe KO. International trends in sudden infant death syndrome: stabilization of rates requires further action. Pediatrics 2008; 122:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/20\">",
"      Hoffman HJ, Damus K, Hillman L, Krongrad E. Risk factors for SIDS. Results of the National Institute of Child Health and Human Development SIDS Cooperative Epidemiological Study. Ann N Y Acad Sci 1988; 533:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/21\">",
"      Poets A, Steinfeldt R, Poets CF. Sudden deaths and severe apparent life-threatening events in term infants within 24 hours of birth. Pediatrics 2011; 127:e869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/22\">",
"      Ostfeld BM, Esposito L, Perl H, Hegyi T. Concurrent risks in sudden infant death syndrome. Pediatrics 2010; 125:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/23\">",
"      MacDorman MF, Cnattingius S, Hoffman HJ, et al. Sudden infant death syndrome and smoking in the United States and Sweden. Am J Epidemiol 1997; 146:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/24\">",
"      Alm B, Milerad J, Wennergren G, et al. A case-control study of smoking and sudden infant death syndrome in the Scandinavian countries, 1992 to 1995. The Nordic Epidemiological SIDS Study. Arch Dis Child 1998; 78:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/25\">",
"      Golding J. Sudden infant death syndrome and parental smoking--a literature review. Paediatr Perinat Epidemiol 1997; 11:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/26\">",
"      Mitchell EA, Milerad J. Smoking and the sudden infant death syndrome. Rev Environ Health 2006; 21:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/27\">",
"      Taylor JA, Sanderson M. A reexamination of the risk factors for the sudden infant death syndrome. J Pediatr 1995; 126:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/28\">",
"      Cohen G, Vella S, Jeffery H, et al. Cardiovascular stress hyperreactivity in babies of smokers and in babies born preterm. Circulation 2008; 118:1848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/29\">",
"      Viskari-L&auml;hdeoja S, Hytinantti T, Andersson S, Kirjavainen T. Heart rate and blood pressure control in infants exposed to maternal cigarette smoking. Acta Paediatr 2008; 97:1535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/30\">",
"      Schneider J, Mitchell I, Singhal N, et al. Prenatal cigarette smoke exposure attenuates recovery from hypoxemic challenge in preterm infants. Am J Respir Crit Care Med 2008; 178:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/31\">",
"      Richardson HL, Walker AM, Horne RS. Maternal smoking impairs arousal patterns in sleeping infants. Sleep 2009; 32:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/32\">",
"      St&eacute;phan-Blanchard E, Chardon K, L&eacute;k&eacute; A, et al. In utero exposure to smoking and peripheral chemoreceptor function in preterm neonates. Pediatrics 2010; 125:e592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/33\">",
"      Kandall SR, Gaines J, Habel L, et al. Relationship of maternal substance abuse to subsequent sudden infant death syndrome in offspring. J Pediatr 1993; 123:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/34\">",
"      Fares I, McCulloch KM, Raju TN. Intrauterine cocaine exposure and the risk for sudden infant death syndrome: a meta-analysis. J Perinatol 1997; 17:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/35\">",
"      Ward SL, Bautista D, Chan L, et al. Sudden infant death syndrome in infants of substance-abusing mothers. J Pediatr 1990; 117:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/36\">",
"      Strandberg-Larsen K, Gr&oslash;nboek M, Andersen AM, et al. Alcohol drinking pattern during pregnancy and risk of infant mortality. Epidemiology 2009; 20:884.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/37\">",
"      Iyasu S, Randall LL, Welty TK, et al. Risk factors for sudden infant death syndrome among northern plains Indians. JAMA 2002; 288:2717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/38\">",
"      Klonoff-Cohen HS, Srinivasan IP, Edelstein SL. Prenatal and intrapartum events and sudden infant death syndrome. Paediatr Perinat Epidemiol 2002; 16:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/39\">",
"      Li DK, Wi S. Maternal pre-eclampsia/eclampsia and the risk of sudden infant death syndrome in offspring. Paediatr Perinat Epidemiol 2000; 14:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/40\">",
"      Smith GC, Wood AM, Pell JP, et al. Second-trimester maternal serum levels of alpha-fetoprotein and the subsequent risk of sudden infant death syndrome. N Engl J Med 2004; 351:978.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/41\">",
"      Malloy MH, Hoffman HJ. Prematurity, sudden infant death syndrome, and age of death. Pediatrics 1995; 96:464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/42\">",
"      Sowter B, Doyle LW, Morley CJ, et al. Is sudden infant death syndrome still more common in very low birthweight infants in the 1990s? Med J Aust 1999; 171:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/43\">",
"      Thompson JM, Mitchell EA, New Zealand Cot Death Study Group. Are the risk factors for SIDS different for preterm and term infants? Arch Dis Child 2006; 91:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/44\">",
"      Bigger HR, Silvestri JM, Shott S, Weese-Mayer DE. Influence of increased survival in very low birth weight, low birth weight, and normal birth weight infants on the incidence of sudden infant death syndrome in the United States: 1985-1991. J Pediatr 1998; 133:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/45\">",
"      Alm B, Norvenius SG, Wennergren G, et al. Changes in the epidemiology of sudden infant death syndrome in Sweden 1973-1996. Arch Dis Child 2001; 84:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/46\">",
"      Blair PS, Platt MW, Smith IJ, et al. Sudden infant death syndrome and sleeping position in pre-term and low birth weight infants: an opportunity for targeted intervention. Arch Dis Child 2006; 91:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/47\">",
"      Bhat RY, Hannam S, Pressler R, et al. Effect of prone and supine position on sleep, apneas, and arousal in preterm infants. Pediatrics 2006; 118:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/48\">",
"      Kassim Z, Donaldson N, Khetriwal B, et al. Sleeping position, oxygen saturation and lung volume in convalescent, prematurely born infants. Arch Dis Child Fetal Neonatal Ed 2007; 92:F347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/49\">",
"      Elder DE, Campbell AJ, Galletly D. Effect of position on oxygen saturation and requirement in convalescent preterm infants. Acta Paediatr 2011; 100:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/50\">",
"      American Academy of Pediatrics Committee on Fetus and Newborn. Hospital discharge of the high-risk neonate. Pediatrics 2008; 122:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/51\">",
"      Malloy MH. Size for gestational age at birth: impact on risk for sudden infant death and other causes of death, USA 2002. Arch Dis Child Fetal Neonatal Ed 2007; 92:F473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/52\">",
"      Guntheroth WG, Lohmann R, Spiers PS. Risk of sudden infant death syndrome in subsequent siblings. J Pediatr 1990; 116:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/53\">",
"      Beal SM, Blundell HK. Recurrence incidence of sudden infant death syndrome. Arch Dis Child 1988; 63:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/54\">",
"      Oyen N, Skjaerven R, Irgens LM. Population-based recurrence risk of sudden infant death syndrome compared with other infant and fetal deaths. Am J Epidemiol 1996; 144:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/55\">",
"      Carpenter RG, Waite A, Coombs RC, et al. Repeat sudden unexpected and unexplained infant deaths: natural or unnatural? Lancet 2005; 365:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/56\">",
"      Beal SM. Siblings of sudden infant death syndrome victims. Clin Perinatol 1992; 19:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/57\">",
"      Getahun D, Demissie K, Lu SE, Rhoads GG. Sudden infant death syndrome among twin births: United States, 1995-1998. J Perinatol 2004; 24:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/58\">",
"      Hoppenbrouwers T, Hodgman JE, Ramanathan A, Dorey F. Extreme and conventional cardiorespiratory events and epidemiologic risk factors for SIDS. J Pediatr 2008; 152:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/59\">",
"      Engelberts AC, de Jonge GA. Choice of sleeping position for infants: possible association with cot death. Arch Dis Child 1990; 65:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/60\">",
"      Fleming PJ, Gilbert R, Azaz Y, et al. Interaction between bedding and sleeping position in the sudden infant death syndrome: a population based case-control study. BMJ 1990; 301:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/61\">",
"      Mitchell EA, Scragg R, Stewart AW, et al. Results from the first year of the New Zealand cot death study. N Z Med J 1991; 104:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/62\">",
"      Beal SM, Finch CF. An overview of retrospective case-control studies investigating the relationship between prone sleeping position and SIDS. J Paediatr Child Health 1991; 27:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/63\">",
"      Guntheroth WG, Spiers PS. Sleeping prone and the risk of sudden infant death syndrome. JAMA 1992; 267:2359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/64\">",
"      Taylor JA, Krieger JW, Reay DT, et al. Prone sleep position and the sudden infant death syndrome in King County, Washington: a case-control study. J Pediatr 1996; 128:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/65\">",
"      Dwyer T, Ponsonby AL, Blizzard L, et al. The contribution of changes in the prevalence of prone sleeping position to the decline in sudden infant death syndrome in Tasmania. JAMA 1995; 273:783.",
"     </a>",
"    </li>",
"    <li>",
"     Gardner P, Hudson B. Advance report of final mortality statistics, 1993. Monthly Vital Statistics Report, vol. 44, National Center for Health Statistics, Hyattsville, Maryland, 1996.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/67\">",
"      Gibson E, Fleming N, Fleming D, et al. Sudden infant death syndrome rates subsequent to the American Academy of Pediatrics supine sleep position. Med Care 1998; 36:938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/68\">",
"      Fleming PJ, Blair PS, Bacon C, et al. Environment of infants during sleep and risk of the sudden infant death syndrome: results of 1993-5 case-control study for confidential inquiry into stillbirths and deaths in infancy. Confidential Enquiry into Stillbirths and Deaths Regional Coordinators and Researchers. BMJ 1996; 313:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/69\">",
"      Willinger M, Hoffman HJ, Wu KT, et al. Factors associated with the transition to nonprone sleep positions of infants in the United States: the National Infant Sleep Position Study. JAMA 1998; 280:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/70\">",
"      Waters KA, Gonzalez A, Jean C, et al. Face-straight-down and face-near-straight-down positions in healthy, prone-sleeping infants. J Pediatr 1996; 128:616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/71\">",
"      Trachtenberg FL, Haas EA, Kinney HC, et al. Risk factor changes for sudden infant death syndrome after initiation of Back-to-Sleep campaign. Pediatrics 2012; 129:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/72\">",
"      Mitchell EA. The changing epidemiology of SIDS following the national risk reduction campaigns. Pediatr Pulmonol Suppl 1997; 16:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/73\">",
"      Li DK, Petitti DB, Willinger M, et al. Infant sleeping position and the risk of sudden infant death syndrome in California, 1997-2000. Am J Epidemiol 2003; 157:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/74\">",
"      Mitchell EA, Tuohy PG, Brunt JM, et al. Risk factors for sudden infant death syndrome following the prevention campaign in New Zealand: a prospective study. Pediatrics 1997; 100:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/75\">",
"      Helweg-Larsen K, Lundemose JB, Oyen N, et al. Interactions of infectious symptoms and modifiable risk factors in sudden infant death syndrome. The Nordic Epidemiological SIDS study. Acta Paediatr 1999; 88:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/76\">",
"      Mitchell EA, Thach BT, Thompson JM, Williams S. Changing infants' sleep position increases risk of sudden infant death syndrome. New Zealand Cot Death Study. Arch Pediatr Adolesc Med 1999; 153:1136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/77\">",
"      L'Hoir MP, Engelberts AC, van Well GT, et al. Sudden unexpected death in infancy: epidemiologically determined risk factors related to pathological classification. Acta Paediatr 1998; 87:1279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/78\">",
"      Mitchell EA, Hutchison L, Stewart AW. The continuing decline in SIDS mortality. Arch Dis Child 2007; 92:625.",
"     </a>",
"    </li>",
"    <li>",
"     United States Food and Drug Administration Safety Alert, 9/29/10. Available at:  file://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm227733.htm.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/80\">",
"      Centers for Disease Control and Prevention (CDC). Suffocation deaths associated with use of infant sleep positioners--United States, 1997-2011. MMWR Morb Mortal Wkly Rep 2012; 61:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/81\">",
"      Mitchell EA, Scragg L, Clements M. Soft cot mattresses and the sudden infant death syndrome. N Z Med J 1996; 109:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/82\">",
"      Hauck FR, Herman SM, Donovan M, et al. Sleep environment and the risk of sudden infant death syndrome in an urban population: the Chicago Infant Mortality Study. Pediatrics 2003; 111:1207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/83\">",
"      Kemp JS, Thach BT. Sudden death in infants sleeping on polystyrene-filled cushions. N Engl J Med 1991; 324:1858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/84\">",
"      Ponsonby AL, Dwyer T, Gibbons LE, et al. Factors potentiating the risk of sudden infant death syndrome associated with the prone position. N Engl J Med 1993; 329:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/85\">",
"      Mitchell EA, Thompson JM, Ford RP, Taylor BJ. Sheepskin bedding and the sudden infant death syndrome. New Zealand Cot Death Study Group. J Pediatr 1998; 133:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/86\">",
"      Vennemann MM, Bajanowski T, Brinkmann B, et al. Sleep environment risk factors for sudden infant death syndrome: the German Sudden Infant Death Syndrome Study. Pediatrics 2009; 123:1162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/87\">",
"      Wilson CA, Taylor BJ, Laing RM, et al. Clothing and bedding and its relevance to sudden infant death syndrome: further results from the New Zealand Cot Death Study. J Paediatr Child Health 1994; 30:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/88\">",
"      Scheers NJ, Dayton CM, Kemp JS. Sudden infant death with external airways covered: case-comparison study of 206 deaths in the United States. Arch Pediatr Adolesc Med 1998; 152:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/89\">",
"      Mitchell EA, Thompson JM, Becroft DM, et al. Head covering and the risk for SIDS: findings from the New Zealand and German SIDS case-control studies. Pediatrics 2008; 121:e1478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/90\">",
"      Blair PS, Mitchell EA, Heckstall-Smith EM, Fleming PJ. Head covering - a major modifiable risk factor for sudden infant death syndrome: a systematic review. Arch Dis Child 2008; 93:778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/91\">",
"      Thach BT, Rutherford GW Jr, Harris K. Deaths and injuries attributed to infant crib bumper pads. J Pediatr 2007; 151:271.",
"     </a>",
"    </li>",
"    <li>",
"     Canadian Paediatric Society. Position statement (CP 2004-02) Recommendations for safe sleeping environments for infants and children. Paediatr Child Health 2004; 9:659 www.cps.ca (Accessed on December 18, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/93\">",
"      Blair PS, Fleming PJ, Smith IJ, et al. Babies sleeping with parents: case-control study of factors influencing the risk of the sudden infant death syndrome. CESDI SUDI research group. BMJ 1999; 319:1457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/94\">",
"      Tappin D, Ecob R, Brooke H. Bedsharing, roomsharing, and sudden infant death syndrome in Scotland: a case-control study. J Pediatr 2005; 147:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/95\">",
"      Vennemann MM, Hense HW, Bajanowski T, et al. Bed sharing and the risk of sudden infant death syndrome: can we resolve the debate? J Pediatr 2012; 160:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/96\">",
"      Lahr MB, Rosenberg KD, Lapidus JA. Bedsharing and maternal smoking in a population-based survey of new mothers. Pediatrics 2005; 116:e530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/97\">",
"      Horsley T, Clifford T, Barrowman N, et al. Benefits and harms associated with the practice of bed sharing: a systematic review. Arch Pediatr Adolesc Med 2007; 161:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/98\">",
"      Ruys JH, de Jonge GA, Brand R, et al. Bed-sharing in the first four months of life: a risk factor for sudden infant death. Acta Paediatr 2007; 96:1399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/99\">",
"      McGarvey C, McDonnell M, Chong A, et al. Factors relating to the infant's last sleep environment in sudden infant death syndrome in the Republic of Ireland. Arch Dis Child 2003; 88:1058.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/100\">",
"      Changing concepts of sudden infant death syndrome: implications for infant sleeping environment and sleep position. American Academy of Pediatrics. Task Force on Infant Sleep Position and Sudden Infant Death Syndrome. Pediatrics 2000; 105:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/101\">",
"      Mosko S, Richard C, McKenna J. Infant arousals during mother-infant bed sharing: implications for infant sleep and sudden infant death syndrome research. Pediatrics 1997; 100:841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/102\">",
"      Does bed sharing affect the risk of SIDS? American Academy of Pediatrics. Task Force on Infant Positioning and SIDS. Pediatrics 1997; 100:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/103\">",
"      McGarvey C, McDonnell M, Hamilton K, et al. An 8 year study of risk factors for SIDS: bed-sharing versus non-bed-sharing. Arch Dis Child 2006; 91:318.",
"     </a>",
"    </li>",
"    <li>",
"     SIDS and KIDS safe sleeping: Cobedding twins. Australia (2010). Available at: file://www.sidsandkids.org/wp-content/uploads/Cobedding-twins1.pdf.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/105\">",
"      Hutchison BL, Stewart AW, Mitchell EA. The prevalence of cobedding and SIDS-related child care practices in twins. Eur J Pediatr 2010; 169:1477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/106\">",
"      Kornhauser Cerar L, Scirica CV, Stucin Gantar I, et al. A comparison of respiratory patterns in healthy term infants placed in car safety seats and beds. Pediatrics 2009; 124:e396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/107\">",
"      C&ocirc;t&eacute; A, Bairam A, Deschenes M, Hatzakis G. Sudden infant deaths in sitting devices. Arch Dis Child 2008; 93:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/108\">",
"      Pollack-Nelson C. Fall and suffocation injuries associated with in-home use of car seats and baby carriers. Pediatr Emerg Care 2000; 16:77.",
"     </a>",
"    </li>",
"    <li>",
"     United States Consumer Products Safety Commission. Infant deaths prompt warning about sling carriers for babies, 3/12/2010. Available at: file://www.cpsc.gov/cpscpub/prerel/prhtml10/10165.html (Accessed on December 13, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/110\">",
"      Committee on Injury, Violence, and Poison Prevention, Durbin DR. Child passenger safety. Pediatrics 2011; 127:788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/111\">",
"      Richardson HL, Walker AM, Horne RS. Minimizing the risks of sudden infant death syndrome: to swaddle or not to swaddle? J Pediatr 2009; 155:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/112\">",
"      Richardson HL, Walker AM, Horne RS. Influence of swaddling experience on spontaneous arousal patterns and autonomic control in sleeping infants. J Pediatr 2010; 157:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/113\">",
"      Scragg RK, Mitchell EA, Stewart AW, et al. Infant room-sharing and prone sleep position in sudden infant death syndrome. New Zealand Cot Death Study Group. Lancet 1996; 347:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/114\">",
"      Hauck FR, Omojokun OO, Siadaty MS. Do pacifiers reduce the risk of sudden infant death syndrome? A meta-analysis. Pediatrics 2005; 116:e716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/115\">",
"      Franco P, Scaillet S, Wermenbol V, et al. The influence of a pacifier on infants' arousals from sleep. J Pediatr 2000; 136:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/116\">",
"      Kahn A, Sawaguchi T, Sawaguchi A, et al. Sudden infant deaths: from epidemiology to physiology. Forensic Sci Int 2002; 130 Suppl:S8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/117\">",
"      l'Hoir MP, Engelberts AC, van Well GT, et al. Case-control study of current validity of previously described risk factors for SIDS in The Netherlands. Arch Dis Child 1998; 79:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/118\">",
"      Wennergren G, Alm B, Oyen N, et al. The decline in the incidence of SIDS in Scandinavia and its relation to risk-intervention campaigns. Nordic Epidemiological SIDS Study. Acta Paediatr 1997; 86:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/119\">",
"      Kraus JF, Greenland S, Bulterys M. Risk factors for sudden infant death syndrome in the US Collaborative Perinatal Project. Int J Epidemiol 1989; 18:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/120\">",
"      Brooke H, Gibson A, Tappin D, Brown H. Case-control study of sudden infant death syndrome in Scotland, 1992-5. BMJ 1997; 314:1516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/121\">",
"      Gilbert RE, Wigfield RE, Fleming PJ, et al. Bottle feeding and the sudden infant death syndrome. BMJ 1995; 310:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/122\">",
"      Bertini G, Perugi S, Dani C, et al. Maternal education and the incidence and duration of breast feeding: a prospective study. J Pediatr Gastroenterol Nutr 2003; 37:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/123\">",
"      Amir LH, Donath SM. Does maternal smoking have a negative physiological effect on breastfeeding? The epidemiological evidence. Breastfeed Rev 2003; 11:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/124\">",
"      Donath SM, Amir LH, ALSPAC Study Team. The relationship between maternal smoking and breastfeeding duration after adjustment for maternal infant feeding intention. Acta Paediatr 2004; 93:1514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/125\">",
"      Noble L, Hand I, Haynes D, et al. Factors influencing initiation of breast-feeding among urban women. Am J Perinatol 2003; 20:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/126\">",
"      Vingraite J, Bartkeviciute R, Michaelsen KF. A cohort study of term infants from Vilnius, Lithuania: feeding patterns. Acta Paediatr 2004; 93:1349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/127\">",
"      Hauck FR, Thompson JM, Tanabe KO, et al. Breastfeeding and reduced risk of sudden infant death syndrome: a meta-analysis. Pediatrics 2011; 128:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/128\">",
"      Coleman-Phox K, Odouli R, Li DK. Use of a fan during sleep and the risk of sudden infant death syndrome. Arch Pediatr Adolesc Med 2008; 162:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/129\">",
"      Hoffman HJ, Hunter JC, Damus K, et al. Diphtheria-tetanus-pertussis immunization and sudden infant death: results of the National Institute of Child Health and Human Development Cooperative Epidemiological Study of Sudden Infant Death Syndrome risk factors. Pediatrics 1987; 79:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/130\">",
"      Griffin MR, Ray WA, Livengood JR, Schaffner W. Risk of sudden infant death syndrome after immunization with the diphtheria-tetanus-pertussis vaccine. N Engl J Med 1988; 319:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/131\">",
"      Jonville-B&eacute;ra AP, Autret-Leca E, Barbeillon F, et al. Sudden unexpected death in infants under 3 months of age and vaccination status- -a case-control study. Br J Clin Pharmacol 2001; 51:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/132\">",
"      Fleming PJ, Blair PS, Platt MW, et al. The UK accelerated immunisation programme and sudden unexpected death in infancy: case-control study. BMJ 2001; 322:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/133\">",
"      Mitchell EA, Stewart AW, Clements M. Immunisation and the sudden infant death syndrome. New Zealand Cot Death Study Group. Arch Dis Child 1995; 73:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/134\">",
"      MacIntyre CR, Leask J. Immunization myths and realities: responding to arguments against immunization. J Paediatr Child Health 2003; 39:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/135\">",
"      Vennemann MM, H&ouml;ffgen M, Bajanowski T, et al. Do immunisations reduce the risk for SIDS? A meta-analysis. Vaccine 2007; 25:4875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/136\">",
"      Guntheroth WG, Spiers PS. The triple risk hypotheses in sudden infant death syndrome. Pediatrics 2002; 110:e64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/137\">",
"      Rognum TO, Saugstad OD. Biochemical and immunological studies in SIDS victims. Clues to understanding the death mechanism. Acta Paediatr Suppl 1993; 82 Suppl 389:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/138\">",
"      Filiano JJ, Kinney HC. A perspective on neuropathologic findings in victims of the sudden infant death syndrome: the triple-risk model. Biol Neonate 1994; 65:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/139\">",
"      Hoffman HJ, Hillman LS. Epidemiology of the sudden infant death syndrome: maternal, neonatal, and postneonatal risk factors. Clin Perinatol 1992; 19:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/140\">",
"      Li DK, Wi S. Maternal placental abnormality and the risk of sudden infant death syndrome. Am J Epidemiol 1999; 149:608.",
"     </a>",
"    </li>",
"    <li>",
"     Hunt CE. Sudden infant death syndrome. In: Respiratory Control Disorders in Infants and Children, Beckerman RC, Brouillette RT, Hunt CE (Eds), Williams &amp; Wilkins, Baltimore 1992.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/142\">",
"      Schechtman VL, Lee MY, Wilson AJ, Harper RM. Dynamics of respiratory patterning in normal infants and infants who subsequently died of the sudden infant death syndrome. Pediatr Res 1996; 40:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/143\">",
"      Panigrahy A, Filiano J, Sleeper LA, et al. Decreased serotonergic receptor binding in rhombic lip-derived regions of the medulla oblongata in the sudden infant death syndrome. J Neuropathol Exp Neurol 2000; 59:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/144\">",
"      Biondo B, Lavezzi A, Tosi D, et al. Delayed neuronal maturation of the medullary arcuate nucleus in sudden infant death syndrome. Acta Neuropathol 2003; 106:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/145\">",
"      Kinney HC, Randall LL, Sleeper LA, et al. Serotonergic brainstem abnormalities in Northern Plains Indians with the sudden infant death syndrome. J Neuropathol Exp Neurol 2003; 62:1178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/146\">",
"      Filiano JJ, Kinney HC. Arcuate nucleus hypoplasia in the sudden infant death syndrome. J Neuropathol Exp Neurol 1992; 51:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/147\">",
"      Machaalani R, Say M, Waters KA. Serotoninergic receptor 1A in the sudden infant death syndrome brainstem medulla and associations with clinical risk factors. Acta Neuropathol 2009; 117:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/148\">",
"      Paterson DS, Trachtenberg FL, Thompson EG, et al. Multiple serotonergic brainstem abnormalities in sudden infant death syndrome. JAMA 2006; 296:2124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/149\">",
"      Duncan JR, Paterson DS, Hoffman JM, et al. Brainstem serotonergic deficiency in sudden infant death syndrome. JAMA 2010; 303:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/150\">",
"      Say M, Machaalani R, Waters KA. Changes in serotoninergic receptors 1A and 2A in the piglet brainstem after intermittent hypercapnic hypoxia (IHH) and nicotine. Brain Res 2007; 1152:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/151\">",
"      Opdal SH, Rognum TO. The sudden infant death syndrome gene: does it exist? Pediatrics 2004; 114:e506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/152\">",
"      Hunt CE. Gene-environment interactions: implications for sudden unexpected deaths in infancy. Arch Dis Child 2005; 90:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/153\">",
"      Wang DW, Desai RR, Crotti L, et al. Cardiac sodium channel dysfunction in sudden infant death syndrome. Circulation 2007; 115:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/154\">",
"      Arnestad M, Crotti L, Rognum TO, et al. Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation 2007; 115:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/155\">",
"      Van Norstrand DW, Valdivia CR, Tester DJ, et al. Molecular and functional characterization of novel glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) mutations in sudden infant death syndrome. Circulation 2007; 116:2253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/156\">",
"      Otagiri T, Kijima K, Osawa M, et al. Cardiac ion channel gene mutations in sudden infant death syndrome. Pediatr Res 2008; 64:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/157\">",
"      Tan BH, Pundi KN, Van Norstrand DW, et al. Sudden infant death syndrome-associated mutations in the sodium channel beta subunits. Heart Rhythm 2010; 7:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/158\">",
"      Tester DJ, Tan BH, Medeiros-Domingo A, et al. Loss-of-function mutations in the KCNJ8-encoded Kir6.1 K(ATP) channel and sudden infant death syndrome. Circ Cardiovasc Genet 2011; 4:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/159\">",
"      Van Norstrand DW, Asimaki A, Rubinos C, et al. Connexin43 mutation causes heterogeneous gap junction loss and sudden infant death. Circulation 2012; 125:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/160\">",
"      Narita N, Narita M, Takashima S, et al. Serotonin transporter gene variation is a risk factor for sudden infant death syndrome in the Japanese population. Pediatrics 2001; 107:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/161\">",
"      Weese-Mayer DE, Zhou L, Berry-Kravis EM, et al. Association of the serotonin transporter gene with sudden infant death syndrome: a haplotype analysis. Am J Med Genet A 2003; 122A:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/162\">",
"      Rahim RA, Boyd PA, Ainslie Patrick WJ, Burdon RH. Human heat shock protein gene polymorphisms and sudden infant death syndrome. Arch Dis Child 1996; 75:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/163\">",
"      Opdal SH, Vege A, Rognum TO. Serotonin transporter gene variation in sudden infant death syndrome. Acta Paediatr 2008; 97:861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/164\">",
"      Nonnis Marzano F, Maldini M, Filonzi L, et al. Genes regulating the serotonin metabolic pathway in the brain stem and their role in the etiopathogenesis of the sudden infant death syndrome. Genomics 2008; 91:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/165\">",
"      Klintschar M, Heimbold C. Association between a functional polymorphism in the MAOA gene and sudden infant death syndrome. Pediatrics 2012; 129:e756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/166\">",
"      Weese-Mayer DE, Berry-Kravis EM, Zhou L, et al. Sudden infant death syndrome: case-control frequency differences at genes pertinent to early autonomic nervous system embryologic development. Pediatr Res 2004; 56:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/167\">",
"      Cummings KJ, Klotz C, Liu WQ, et al. Sudden infant death syndrome (SIDS) in African Americans: polymorphisms in the gene encoding the stress peptide pituitary adenylate cyclase-activating polypeptide (PACAP). Acta Paediatr 2009; 98:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/168\">",
"      Opdal SH, Vege A, Stave AK, Rognum TO. The complement component C4 in sudden infant death. Eur J Pediatr 1999; 158:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/169\">",
"      Summers AM, Summers CW, Drucker DB, et al. Association of IL-10 genotype with sudden infant death syndrome. Hum Immunol 2000; 61:1270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/170\">",
"      Opdal SH, Opstad A, Vege A, Rognum TO. IL-10 gene polymorphisms are associated with infectious cause of sudden infant death. Hum Immunol 2003; 64:1183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/171\">",
"      Korachi M, Pravica V, Barson AJ, et al. Interleukin 10 genotype as a risk factor for sudden infant death syndrome: determination of IL-10 genotype from wax-embedded postmortem samples. FEMS Immunol Med Microbiol 2004; 42:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/172\">",
"      Puffenberger EG, Hu-Lince D, Parod JM, et al. Mapping of sudden infant death with dysgenesis of the testes syndrome (SIDDT) by a SNP genome scan and identification of TSPYL loss of function. Proc Natl Acad Sci U S A 2004; 101:11689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/173\">",
"      Opdal SH, Rognum TO. New insight into sudden infant-death syndrome. Lancet 2004; 364:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/174\">",
"      Meny RG, Carroll JL, Carbone MT, Kelly DH. Cardiorespiratory recordings from infants dying suddenly and unexpectedly at home. Pediatrics 1994; 93:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/175\">",
"      Groswasser J, Simon T, Scaillet S, et al. Reduced arousals following obstructive apneas in infants sleeping prone. Pediatr Res 2001; 49:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/176\">",
"      Horne RS, Ferens D, Watts AM, et al. The prone sleeping position impairs arousability in term infants. J Pediatr 2001; 138:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/177\">",
"      Wong FY, Witcombe NB, Yiallourou SR, et al. Cerebral oxygenation is depressed during sleep in healthy term infants when they sleep prone. Pediatrics 2011; 127:e558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/178\">",
"      Chiodini BA, Thach BT. Impaired ventilation in infants sleeping facedown: potential significance for sudden infant death syndrome. J Pediatr 1993; 123:686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/179\">",
"      Guntheroth WG, Spiers PS. Thermal stress in sudden infant death: Is there an ambiguity with the rebreathing hypothesis? Pediatrics 2001; 107:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/180\">",
"      Thompson JM, Thach BT, Becroft DM, et al. Sudden infant death syndrome: risk factors for infants found face down differ from other SIDS cases. J Pediatr 2006; 149:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/181\">",
"      Southall DP, Stevens V, Franks CI, et al. Sinus tachycardia in term infants preceding sudden infant death. Eur J Pediatr 1988; 147:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/182\">",
"      Schwartz PJ, Stramba-Badiale M, Segantini A, et al. Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med 1998; 338:1709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/183\">",
"      Ackerman MJ, Siu BL, Sturner WQ, et al. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA 2001; 286:2264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/184\">",
"      Plant LD, Bowers PN, Liu Q, et al. A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103Y. J Clin Invest 2006; 116:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/185\">",
"      Weber MA, Ashworth MT, Risdon RA, et al. The role of post-mortem investigations in determining the cause of sudden unexpected death in infancy. Arch Dis Child 2008; 93:1048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/186\">",
"      Highet AR. An infectious aetiology of sudden infant death syndrome. J Appl Microbiol 2008; 105:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/187\">",
"      Goldwater PN. SIDS pathogenesis: pathological findings indicate infection and inflammatory responses are involved. FEMS Immunol Med Microbiol 2004; 42:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/188\">",
"      Goldwater PN. Sterile site infection at autopsy in sudden unexpected deaths in infancy. Arch Dis Child 2009; 94:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/189\">",
"      Weber MA, Klein NJ, Hartley JC, et al. Infection and sudden unexpected death in infancy: a systematic retrospective case review. Lancet 2008; 371:1848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/190\">",
"      Creery D, Mikrogianakis A. Sudden infant death syndrome. Clin Evid 2005; :434.",
"     </a>",
"    </li>",
"    <li>",
"     Reduce the risk of cot death (September 2005). United Kingdom Department of Health www.dh.gov.uk/assetRoot/04/12/36/26/04123626.pdf (Accessed on March 08, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/192\">",
"      Recommendations for safe sleeping environments for infants and children. Paediatr Child Health 2004; 9:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/193\">",
"      Colson ER, Joslin SC. Changing nursery practice gets inner-city infants in the supine position for sleep. Arch Pediatr Adolesc Med 2002; 156:717.",
"     </a>",
"    </li>",
"    <li>",
"     National SUID/SIDS resource center. What works: Changing knowledge and behavior to reduce sudden unexpected infant death. Available at: file://www.sidscenter.org/whatworks.html (Accessed on April 11, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/195\">",
"      Mitchell EA. Recommendations for sudden infant death syndrome prevention: a discussion document. Arch Dis Child 2007; 92:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/196\">",
"      Howard CR, Howard FM, Lanphear B, et al. Randomized clinical trial of pacifier use and bottle-feeding or cupfeeding and their effect on breastfeeding. Pediatrics 2003; 111:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/20/37194/abstract/197\">",
"      Uhari M, M&auml;ntysaari K, Niemel&auml; M. A meta-analytic review of the risk factors for acute otitis media. Clin Infect Dis 1996; 22:1079.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6366 Version 20.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-190.81.197.98-D795AC79FE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_20_37194=[""].join("\n");
var outline_f36_20_37194=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H33\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6270397\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6270404\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Maternal risk factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6286769\">",
"      Infant risk factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Prematurity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Low birthweight",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6286913\">",
"      - Sibling of SIDS victim",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6286944\">",
"      - Twins",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6178967\">",
"      - History of apnea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Sleep position",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Sleep environment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13238420\">",
"      Protective factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Underlying vulnerability",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Brain abnormalities",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Genetic factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Environmental triggers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Developmental timing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6286180\">",
"      Prenatal measures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6286188\">",
"      Sleep position and environment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9951026\">",
"      Other measures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      No benefit from home monitors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6366\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6366|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?28/1/28691\" title=\"figure 1\">",
"      Safe bedding for infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6366|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?3/47/3837\" title=\"table 1\">",
"      Disorders that can mimic SIDS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?27/60/28620\" title=\"table 2\">",
"      Risk factors for SIDS",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/60/29642?source=related_link\">",
"      Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/34/31272?source=related_link\">",
"      Apparent life-threatening event in infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/39/42616?source=related_link\">",
"      Breastfeeding: Parental education and support",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/9/2202?source=related_link\">",
"      Clinical features of congenital long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/58/41895?source=related_link\">",
"      Control of secondhand smoke exposure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/46/30441?source=related_link\">",
"      Gastroesophageal reflux in infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/47/32505?source=related_link\">",
"      Infant benefits of breastfeeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/13/43223?source=related_link\">",
"      Management of apnea of prematurity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/37/10841?source=related_link\">",
"      Overview of craniosynostosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?7/40/7811?source=related_link\">",
"      Patient information: Sudden infant death syndrome (SIDS) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/38/38497?source=related_link\">",
"      Patient information: Sudden infant death syndrome (SIDS) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/4/5194?source=related_link\">",
"      Secondhand smoke exposure: Effects in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/0/36872?source=related_link\">",
"      Sudden unexpected infant death including SIDS: Initial management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/58/21414?source=related_link\">",
"      Use of home cardiorespiratory monitors in infants",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_20_37195="Clinical features Dents disease";
var content_f36_20_37195=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F74862&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F74862&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical features of patients with documented mutations in CLCN-5",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Abnormality",
"       </td>",
"       <td class=\"subtitle1\">",
"        Prevalence, percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LMW proteinuria",
"       </td>",
"       <td>",
"        100",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypercalciuria*",
"       </td>",
"       <td>",
"        95",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hematuria",
"       </td>",
"       <td>",
"        94",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nephrocalcinosis",
"       </td>",
"       <td>",
"        74",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nephrolithiasis",
"       </td>",
"       <td>",
"        49",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal failure",
"       </td>",
"       <td>",
"        64",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rickets or osteomalacia",
"       </td>",
"       <td>",
"        30",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Concentrating defect",
"       </td>",
"       <td>",
"        81",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Aminoaciduria",
"       </td>",
"       <td>",
"        76",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Glycosuria",
"       </td>",
"       <td>",
"        54",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypophosphatemia",
"       </td>",
"       <td>",
"        50",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypokalemia",
"       </td>",
"       <td>",
"        35",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acidification defect",
"       </td>",
"       <td>",
"        17",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Excludes patients with reduced renal function.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Scheinman SJ. Semin Nephrol 1999; 19:381. Copyright &copy; 1999 Elsevier Science.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_20_37195=[""].join("\n");
var outline_f36_20_37195=null;
var title_f36_20_37196="AC pregnancy mechanical valve";
var content_f36_20_37196=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F81671&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F81671&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    ACC/AHA guideline summary: Anticoagulation regimen in pregnant women with mechanical prosthetic heart valves",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class I - There is evidence and/or general agreement that the following approaches to anticoagulation therapy are indicated in pregnant women with mechanical prosthetic heart valves:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; For women who are attempting to become pregnant, anticoagulation options during pregnancy are discussed so that anticoagulation can be uninterrupted once pregnancy is achieved. Because of the risk of warfarin embryopathy between 6 and 12 weeks of gestation, pregnancy tests should be monitored.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; During pregnancy, continuous therapeutic anticoagulation with frequent monitoring.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Women who elect to stop warfarin between 6 and 12 weeks of gestation should be treated with dose-adjusted continuous intravenous unfractionated heparin (UFH), subcutaneous UFH, or low molecular weight heparin (LMWH).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        &bull; Between 12 and 36 weeks, the patient can be treated with dose-adjusted continuous intravenous UFH, subcutaneous UFH, or LMWH, or warfarin. With warfarin compared to the different heparin regimens, the fetal risk is higher but the maternal risk appears to be lower for prosthetic valve thrombosis and systemic embolization. Heparin therapy, particularly UFH, also carries the risks of heparin-induced thrombocytopenia and osteoporosis.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        1. Dose-adjusted LMWH should be given twice daily subcutaneously to maintain the anti-Xa level between 0.7 and 1.2 U/mL at four hours after dosing. LMWH should NOT be given if such monitoring cannot be performed.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        2. With dose-adjusted UFH, the aPTT should be at least twice control.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        3. With warfarin, the goal INR is 3.0 (range 2.5 to 3.5). Warfarin should be discontinued and continuous intravenous UFH started beginning two to three weeks before planned delivery.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class IIa - The weight of evidence or opinion is in favor of the usefulness of the the following approaches to anticoagulation therapy in pregnant women with mechanical prosthetic heart valves:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Avoidance of warfarin between 6 and 12 weeks of gestation due to the high risk of fetal defects.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; In the absence of significant bleeding, continuous intravenous heparin should be resumed and oral warfarin should be begun four to six hours after delivery.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; In the second and third trimesters, low-dose aspirin (75 to 100 mg/day) can be given in addition to warfarin or heparin. Dipyridamole is NOT an alternative to aspirin because of its adverse effects on the fetus.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Bonow RO, Carabello BA, Chatterjee K, et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 52:e1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_20_37196=[""].join("\n");
var outline_f36_20_37196=null;
var title_f36_20_37197="Radiographic patterns in ILD I";
var content_f36_20_37197=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F69806&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F69806&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Helpful radiographic patterns in the differential diagnosis of interstitial lung disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            End-stage or honeycomb lung",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Upper zone predominance",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Sarcoidosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Pulmonary Langerhans cell histiocytosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Chronic hypersensitivity pneumonitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Lymphangioleiomyomatosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Lower zone predominance",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Idiopathic pulmonary fibrosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Rheumatoid arthritis (associated with usual interstitial pneumonia)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Asbestosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Increased lung volumes",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lymphangioleiomyomatosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tuberous sclerosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sarcoidosis (stage 3)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pulmonary Langerhans cell histiocytosis&nbsp;(chronic, with cyst formation)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Neurofibromatosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Chronic hypersensitivity pneumonitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Reticular or nodular infiltration, increased lung volumes and bullous changes",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lymphangioleiomyomatosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tuberous sclerosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Neurofibromatosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Chronic sarcoidosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pulmonary Langerhans cell histiocytosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Chronic hypersensitivity pneumonia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Endstage pulmonary involvement in microscopic polyangiitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Intravenous drug abuse (Ritalin)",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Associated with pneumothorax",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pulmonary Langerhans cell histiocytosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lymphangioleiomyomatosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tuberous sclerosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Pleural involvement",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Asbestosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Connective tissue disorders",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1 sublist1\">",
"            Systemic lupus erythematosus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1 sublist1\">",
"            Rheumatoid arthritis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1 sublist1\">",
"            Scleroderma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1 sublist1\">",
"            Mixed connective tissue disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lymphangitic carcinomatosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lymphangioleiomyomatosis (chylous effusion)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Drug-induced (nitrofurantoin)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sarcoidosis (lymphocytic effusion)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Radiation pneumonitis (chronic with mediastinal lymphatic obstruction)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Hilar or mediastinal lymphadenopathy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sarcoidosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lymphoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Kaposi's sarcoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Methotrexate-induced lung disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lymphangitic carcinomatosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Berylliosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Amyloidosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Gaucher's disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Acute disseminated histoplasmosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Acute disseminated coccidioidomycosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Eggshell calcification of lymph nodes",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Silicosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sarcoidosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Radiation",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_20_37197=[""].join("\n");
var outline_f36_20_37197=null;
var title_f36_20_37198="Hepatic metabolism";
var content_f36_20_37198=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F74094&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F74094&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 569px\">",
"   <div class=\"ttl\">",
"    Hepatic drug metabolism",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 549px; height: 299px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_20_37198=[""].join("\n");
var outline_f36_20_37198=null;
var title_f36_20_37199="Lung cancer extension CT";
var content_f36_20_37199=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F74264&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F74264&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Transdiaphragmatic extension of lung carcinoma on CT",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 338px; height: 276px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Contrast-enhanced CT sections through the lower chest and liver show an irregular low-attenuation lesion in the right hepatic lobe (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_20_37199=[""].join("\n");
var outline_f36_20_37199=null;
